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LIST OF ABBREVIATIONS 
APC - antigen-presenting cell 
CD - cluster of differentiation 
Con-A - concanavalin A 
DMEM - Dulbecco's modified Eagle's medium 
Ea-B - erythrocyte alloantigen, chicken blood group locus 
GAT - poly(glutamic acid^-alanine^°-tyrosine^°) 
GVH - graft versus host 
IgG - immunoglobulin G 
IL-2 - interleukin 2 
Ir-GAT - gene or genes responsible for humoral immune response to GAT 
Kd - kilodalton 
MD - Marek's disease 
MDV - Marek's disease virus 
MG - Mycoplasma gall isepticum 
MHC - major histocompatibility complex 
MTT - 3-(4,5-d1methylth1azol-2-yl)-2,5-d1phenyl tetrazolium bromide 
NOR - nucleolar organizer region 
PBS - phosphate buffered saline 
PHA - phytohemagglutinin 
PM - Pasteurella muHocida 
RBC - red blood cell 
RFLP - restriction fragment length polymorphism 
RSV - Rous sarcoma virus 
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INTRODUCTION 
Among genetic markers linked to disease resistance in chickens, the 
major histocompatibility complex (MHC) is the most widely studied. 
Chickens with particular MHC alleles have been found to be more resistant 
to Marek's disease (Hanson et al. 1967, Steadham et al. 1987), Rous 
sarcoma virus-induced tumors (Collins et al. 1977, Schierman et a7. 1977) 
and fowl cholera (Lamont et al. 1987). Adult mortality levels have also 
been linked to the MHC in chickens (Nordskog et al. 1977). Humoral immune 
response, as measured by antibody titer produced in response to challenge 
with the amino acid polymer GAT [Poly (Glu" Ala^° Tyr^°)], has also been 
associated with the chicken MHC (Benedict et al. 1975). These observa­
tions are not surprising, because the gene products of the MHC contribute 
to recognition and interaction among cells of the immune system (Clark 
1983, Klein 1986). Genetic selection for improved general disease 
resistance through selection for immune response characteristics or 
markers is an attractive possibility and has the advantage of not risking 
valuable genetic stock by direct disease challenge (Gavora and Spencer 
1983). 
Immune response (Jr) genes were first described in outbred lines of 
guinea pigs (Levine et a/. 1963). The ability to respond (as measured by 
antibody production) when challenged with dinitrophenyl-poly-L-lysine was 
found to be under control of a single autosomal dominant gene. The 
availability of inbred mouse strains enabled McDevitt and Chintz (1969) to 
link response to the branched amino acid polymer (T,G)-A-L to the mouse 
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MHC. Recombinants within the mouse MHC allowed for the mapping of the Ir-
(T,G)-A-L gene within the I region of the MHC (McDevitt et al. 1972). 
Benedict et al. (1975) described the close association between 
Immune response to GAT {Ir-GAT) and the chicken B complex (MHC). Pevzner 
et al. (1978) reported on the recombination between the gene(s) for Ir-GAT 
and the serologically determined MHC genes {Ea-B or B-F/B-G) in the Iowa 
State University SI line of chickens. Based on structural and functional 
homology, the gene products of the B-L region of the chicken MHC are the 
equivalent of the mouse MHC I region (Hala et al. 1981). Thé original 
hypothesis was that the dichotomy between Ea-B and Ir-GAT could be due to 
a recombinational event between the B-F/B-G subrogions and the B-L 
subregion of the chicken MHC. 
Attempts to detect evidence of chromosomal recombination in the SI 
line expressed as a difference In cell surface proteins have proven 
unsuccessful. Restriction fragment length polymorphisms (RFLP) generated 
by probing SI line DNA with a B-L gene probe have been associated with Ea-
B differences (Pitcovski et al. 1989). No RFLP were associated with 
differences in Ir-GAT. It appears that humoral immune response to GAT in 
the SI line could be determined by mechanisms of cell interaction other 
than those mediated through class II molecules. Possibly the contri­
butions of the T cells to immune response (subject to MHC restriction) 
could be a determining factor. The research presented in this disserta­
tion intends to clarify the nature of the antibody response to GAT in the 
SI line of chickens by examining the response of antigen-primed 
lymphocytes when exposed to GAT in vitro. 
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LITERATURE REVIEW 
A large body of work has accumulated describing the details of the 
chicken major histocompatibility complex (MHC). The earliest papers 
describe the biochemical aspects of the gene products. More recent work 
describes the genomic organization of the complex. The details emerging 
from these studies will be discussed in the following review. In 
addition, the Iowa State SI line of chickens has been widely used in 
immunogenetic studies, many of which describe the association of 
particular MHC alleles with resistance or susceptibility to diseases of 
economic impact in poultry. The relationships of humoral immune response 
to glutamic acid-alanine-tyrosine (Ir-GAT) and various poultry diseases 
and immune response characteristics have also been reported in studies 
using the SI line of chickens. These studies indicate the importance in 
understanding the underlying mechanisms that could account for the 
differences in response to GAT, as well as the differences in disease 
susceptibility. While the mechanisms involved in immune response are 
well-studied in mammals, progress in understanding the mechanisms in non-
mammalian species is at a much lower level. 
The Chicken Major Histocompatibility Complex {B Complex) 
Based on functional and structural homologies to mammalian systems, 
the B complex is the chicken major histocompatibility complex (MHC) 
(Pazderka et al. 1975a). The B complex was first described as a gene (fa-
B) controlling an alloantigen expressed on the surface of chicken 
erythrocytes (Briles et al. 1950). In 1961, Schierman and Nordskog 
reported on the linkage of Ea-B and the gene(s) controlling skin graft 
acceptance or rejection. Later, Miggiano et a7. (1974) demonstrated that 
the mixed lymphocyte reaction (the proliferative response of cells when 
mixed in culture with non-self cells) in chickens is controlled by the 
genes of the B complex. The close association of Ea-B and 
histocompatibility led to the chicken MHC being named the B complex. 
The major elements of the B complex can be explained by the three 
locus model proposed by Pink et a7. (1977). Based on tissue distribution 
and functional and biochemical analyses, there are three types of antigens 
or antigenic complexes that are genetically coded within the chicken MHC. 
These antigens are expressed on the surface of cells as transmembranous 
proteins. The three types of gene products are the B-F, B-L, and B-G 
antigens. 
The B-F (Class I) gene products have the widest tissue distribution 
throughout the chicken and are found on most somatic cells, peripheral 
blood lymphocytes (PBL), and red blood cells and their precursors (Pink et 
al. 1977, Héla et al. 1981). The B-F gene product is a 40-45 Kd 
glycoprotein that is non-covalently associated on the cell surface with 
microglobulin, which is coded for outside of the B complex (Pink et al. 
1985). The B-F is the apparent homologue of the mouse MHC Class I (K or 
D) antigen and as such is a highly polymorphic classical transplantation 
antigen. 
The B-L (Class II) region gene products have a narrower cellular 
distribution pattern. The B-L antigens are found on B cells and cells of 
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monocyte/macrophage lineage (Hdla et al. 1981). As expressed on the cell 
surface, the B-L antigen Is a transmembranous non-covalent heterodlmer 
composed of a relatively Invariant a chain (32-34 Kd) and a polymorphic p 
chain with an apparent molecular size of 27-29 Kd (Ewert et al. 1984, 
Guillemot et al. 1986). It is widely accepted that the B-L region of 
chickens is the homologue of the mouse MHC I region or the human MHC D 
region (Héla et al. 1981). 
The B-G (Class IV) region codes for the polymorphic alloantigens 
found primarily on erythrocytes and their precursors. There are no known 
mammalian homologues for the B-G region gene products and there are no 
known immunological functions associated with B-G antigens. As expressed 
on the surface of erythrocytes, the B-G antigen is a disulfide-linked 
homodimer (40-48 Kd/chain) and is not glycosylated (Salomonsen et al. 
1987, Morgan et al. 1990). The variation in apparent molecular size may 
be due to the length of the cytoplasmic portion of the molecule (Guillemot 
et al. 1989). The presence of B-F and B-G antigens on erythrocytes forms 
the basis of MHC typing in chickens by hemagglutination with alloantisera. 
Genomic organization of the B complex 
The molecular map of the chicken MHC is far from complete, but 
recent reviews have pointed out some homologies and some differences 
compared to the mammalian MHC (Guillemot et al. 1989, Kroemer et al. 
1990). Sequence homology between a human MHC Class II P gene and chicken 
B-L provided an entry point into the chicken MHC. Subsequently, 
specific chicken B-F ct, B-L 0, and B-G gene probes were developed and 
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characterized by chromosome walking. These probes were in turn used to 
identify and map MHC genes on four non-overlapping cosmids constructed 
from chicken DNA of the haplotype. The cosmids covered 320 Kb of the 
chicken MHC and nucleolar organizer region (NOR). The NOR contains the 
DNA for two ribosomal RNA genes and has been linked to the B complex 
(Bloom and Bacon 1985) and marks the telomeric end of the chicken MHC 
(Guillemot et al. 1988). The distances between Class I (B-F) and Class II 
{B-L) genes are extremely small when compared to mammalian MHC. The four 
cosmids also contained more than one boundary between Class I and Class II 
genes, indicating that they are interspersed along the length of the 
complex. The compactness of the coding regions and their arrangement may 
account for the failure to detect recombination between Class I and Class 
II genes often reported in the literature (Skjgdt et al. 1985, Hàla et al. 
1988). Unlike the mammalian MHC, there do not appear to be Class III 
genes (coding for some complement serum proteins) within the chicken MHC 
(Guillemot et al. 1988). 
There are also non-Class I and non-Class II genes scattered among 
the B-F and B-L genes, at least some of which are transcribed to mRNA. 
The function of these genes is not known. Kroemer et al. (1990) have 
speculated that they may be equivalent to mouse Qa/Tl genes (Class I). 
One of the transcribed genes appears to code for a subunit of the GTP-
binding protein (G protein) which is not in the mammalian MHC (Guillemot 
et al. 1989a). The G proteins function in transmembrane signalling in 
immune cells (as well as other cell types) and thus could have 
immunological significance (Neer and Clapham 1988). 
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The ISU SI Line of Chickens 
The SI line of Leghorn chickens originated at Iowa State University 
from a cross of two Inbred commercial white Leghorn lines in 1963 
(Nordskog et al. 1973). Selection at that time was based solely on the B 
blood group (which marked the MHC type); all combinations of homozygotes 
and heterozygotes were produced each generation. There was no selection 
based on performance or viability traits. Full and half-sib matlngs were 
avoided. The original alleles segregating in the SI line were b\ B^, B^', 
and B^'. 
Since the foundation of the SI line, the B^' MHC haplotype has been 
dropped from the matlngs and the chickens have been maintained as sublines 
since 1978 (Pevzner et al. 1978). The sublines are based on their MHC 
type (B^ or B^') and their humoral Immune response (high or low) when 
challenged with GAT. The B^ haplotype has been maintained as a control 
within the SI line. Matlngs within the five sublines (Table 1) were 
random until 1983. Since that time the sublines have been maintained with 
avoidance of full or half-sib matlngs. 
Immunoaenetic studies in the ISU SI line of chickens 
There have been many Immune response and disease resistance studies 
conducted using the SI line. In 1972 and 1973, SI line hens (MHC types 
B^B\ B^B^, or B^B^') were inoculated with Salmonella pullorum bacterin and 
their immune response was measured by agglutination assay (Pevzner et al. 
1975). The homozygotes were significantly lower antibody producers than 
the b' heterozygotes. A divergent selection experiment within the B^ 
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Table 1. Blood types and GAT response designations for SI line MHC 
haplotypes used in this dissertation 
Blood Type GAT Response 
Haplotype 
Designation 
Alternative 
Designation 
19 High 19H B19H 
19 Low 19L B19L 
1 High IH B^H 
1 Low IL b"-
2 Intermediate 2 B^ 
haplotype for response to 5. puTlorum indicated that a fourfold difference 
in antibody titer could be reached after three generations of selection 
(Pevzner et al. 1977). The genetic basis was thought to be polygenic 
with perhaps as few as one gene linked to the MHC. High adult mortality 
and lower egg production had also been associated with the homozygotes 
(Nordskog et al. 1973) and was thought to demonstrate the pleiotropic 
nature of the MHC or linkage to a viability or fitness genes. 
In 1978, Pevzner et al. reported evidence of recombination between 
the serologically detectable MHC gene products (B-G and B-F) and the gene 
or genes responsible for immune response to GAT {Ir-GAT). When immunized 
with GAT, the secondary immune response as measured by radioimmunoassay 
(RIA) was clearly associated with the B complex. The B^ homozygotes were 
low or non-responders {Ir-GAT^) and the B^' homozygotes were high 
responders {Ir-GAT^) (5.2 and 53.1% GAT bound respectively). The 
appropriate backcrosses indicated linkage between immune response to GAT 
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and the B complex and that high response was a dominant trait. The 
percentage of GAT bound was different in the backcross chickens. For 
example, the b' homozygotes derived from bVb'XBVb'' matings averaged 16.2% 
GAT bound. There were exceptional individuals whose response was like 
that of the other MHC type (i.e. B^B^ Ir-GAT*). Progeny testing of these 
chickens met expectations of Mendelian segregation and lent support to the 
hypothesis of recombination between Ea-B (the region coding for the 
serologically detectable MHC proteins) and Ir-6AT, the locus responsible 
for response to GAT. 
It should be noted that the SI line was maintained at this time as 
random-bred MHC heterozygotes and homozygotes that would allow recombina­
tion. There was also the possibility that Ir-GAT^ could have been 
involved in a recombination, but the immune response to GAT in the B^ 
haplotype chickens was not as clearly defined as the B^ or the B^' Ir-GAT. 
The Immune responses to other antigens were also examined In the 31 
line. The B^ homozygotes were also low responders (as measured by anti­
body production) to (T,G)-A-L (a branched amino acid polymer of tyrosine, 
glutamic acid, alanine, and lysine) and human serum albumin (HSA) and GT 
(a linear amino acid polymer of glutamic acid and tyrosine). Chickens 
that were of the b" haplotype were high responders to (T,G)-A-L and HSA 
and low or non-responders to GT (Pevzner et al. 1979). 
From 1978 to the present, the SI line has been maintained as 
sublines through intra-haplotype mating by forced segregation for the 
serologically detectable MHC antigens and Ir-GAT type. Immunogenetic 
studies using the SI line since the creation of the sublines have 
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exploited Ir-GAT as an additional genetic marker and various disease 
response traits have been associated with the locus. In 1979, Gebriel et 
al. determined that chickens within the haplotype were more resistant 
to Rous sarcoma virus (RSV) induced tumor development if they were also 
high responders to GAT. A subsequent study (Gebriel and Nordskog 1983) 
using SI chickens of the B^' haplotype that had been characterized for 
GAT response provided additional evidence that the Rs locus controlling 
tumor regression was linked to Ir-GAT. Again, GAT low responder chickens 
were more susceptible to tumor progression. 
Previous investigators had also shown that the MHC was linked to the 
gene or genes controlling outcome of RSV-induced tumors (Collins et al. 
1977, Schierman et al. 1977). Gebriel's study suggested that the response 
to the RSV-induced tumors was at least partially controlled by a gene 
linked to the Ir region of the MHC, assuming that the Ir-GAT gene was 
found in that region. 
The I region genes of the mouse MHC were identified as immune 
response genes and la antigens (their gene product) were found while 
attempting to identify immune response gene products serologically through 
reciprocal immunizations between high and low responders to antigen 
(Shreffler and David 1975). Caution should be exercised when comparing 
mouse immune response mechanisms to those of chicken immune response. The 
limited antigen diversity of linear amino acid polymers insures that most 
inbred mouse lines either respond or do not respond (Benacerraf and Dorf 
1977). Chickens are not non-responders to GAT but are low responders 
(Benedict et al. 1975). 
Chickens representing the four sublines, as well as the within line 
bVb^ control, were challenged by inoculation with the JM strain of 
Marek's disease virus (Pevzner et al. 1981). Low responders to GAT were 
more susceptible to Marek's disease. Both bVb^ and had an 
incidence of the disease slightly above fifty percent. The Ir-GAf* 
chickens within each blood type had a significantly lower incidence of the 
disease. Chickens of the bVb' Ir-GAT^ group had no mortality from Marek's 
disease. Mortality of the B"/B^' Ir-GAT^ chickens was significantly 
higher than zero but still lower than the Ir-GAt- chickens. In other 
lines of chickens the haplotype had previously been identified as 
being particularly susceptible to the effects of Marek's disease (Pazderka 
et a7. 1975). 
A similar Marek's disease challenge was conducted on subsequent 
generations of SI line chickens (for complete text see Appendix). Two 
sequential generations and a later population were challenged with the 
JM strain of MDV and mortality due to the disease and incidence of Marek's 
induced tumors was recorded (Steadham et al. 1987). Results confirmed 
Pevzner's observation that the Ir-GAT* chickens had lower incidence of 
disease and that the chickens were more susceptible than the b'/B^ 
regardless of their GAT response phenotype. 
The Fg chickens were generated by first crossing B^'" and B^"-, as well 
as B^'*" and B^", to produce an F^ population. The sublines were then 
rederived by inter se matings of the F, to produce the Fg population. 
Chickens of the F^ generation were then challenged with MDV. Five genetic 
types were generated: bVb' Ir-GAT", bVb^ Ir-GAf-, B"/B" Ir-GA'f, 
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B'Vb" -Ir-GAf-, and bVb" Ir-GAT\ The group was significantly 
different in resistance to Marek's disease. The data from this trial 
confirmed the increased MD resistance of chickens possessing the bVb' 
blood type when associated with the genes for high immune response to GAT. 
These results suggested the possible role for complementary gene 
loci linked to the MHC and Ir-GAT gene. Reassortment of complementary 
gene loci would have likely occurred in generating the Fg population. 
This also concurs with the assumption that immune response to GAT is in 
part under polygenic control with at least one gene within or closely 
linked to the MHC (Benedict et al. 1975). 
There has been one disease challenge study in the SI line using a 
bacterial pathogen (Lamont et a7. 1987). This was the first instance in 
which the MHC was linked to resistance to a bacterial disease. 
Pasteurella muHocida, the bacterium that causes fowl cholera, was 
inoculated intramuscularly into three-week-old chicks. The chicks used 
were assayed for B-G alloantigen type (B^ or B^') and were characterized 
for Ir-GAT as well as response to RSV-induced tumor (regressor phenotype 
or progresser phenotype). Genetic control of resistance to high doses of 
P. muHocida was associated with RSV type and Ir-GAT type. Both RSV 
regressors and Ir-GAf" type chickens better survived challenge. However, 
the strain and dose of bacterium was such that mortality levels reached 
87% in 24 hours. Two additional replicates of the experiment were 
conducted with a lower dose of inoculum. The Ea-B type was associated 
with resistance in these trials. The B^ type survived challenge better 
than the B". Neither GAT response nor RSV type had a significant effect 
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on survivability. These results were confirmed when F, hétérozygotes and 
Fg homozygotes and heterozygoses were challenged. 
Assays measuring immunological response traits have also been 
conducted with SI line chickens. A study published in 1981 (Rees and 
Nordskog) reported on the maturation of basal serum immunoglobulin G (IgG) 
levels through 21 weeks of age. Chickens that were of the high responder 
type reached greater concentrations of IgG than Ir-GAT^ chickens. 
Analysis of variance on results across other lines and haplotypes 
indicated that line effects were significant, but a genetic component was 
still controlled by the MHC. 
Experiments were also undertaken to identify which MHC subregions in 
the SI line are involved in cell-mediated alloantigen reactions, 
specifically the graft versus host (GVH) reaction (Lee and Nordskog 1981). 
Splenomegaly (spleen enlargement) is induced in immuno-incompetent chick 
embryos when immunologically competent lymphocytes of different MHC type 
are injected intravenously (Jaffe and McDermid 1962). Strong GVH. 
reactions in mice are due to differences in the I region (Class II) and 
weaker, but still significant, reactions are induced when there are 
differences in the K or D (Class I) region of the MHC (Klein and Park 
1973). In the SI line, splenomegaly was greatest when there were 
differences in the B blood group antigens (presumably, B-G/B-F) and 
differences were smaller, albeit significant, when there were Ir-GAT 
differences between host and donor. 
A series of immunocompetence measurements were taken on SI line 
chickens by Cheng and Lamont (1988). Humoral immune response to 
immunization with P. muHocida (PM) and Mycoplasma gall isepticum (MG) 
bacterins was measured by enzyme-linked-immunosorbant-assay (ELISA). A 
carbon clearance assay was used to measure in vivo phagocytic ability. 
Phytohemagglutinin (PHA) was injected intradermally in the wing web to 
evaluate T cell mediated response (recruitment and proliferation) in vivo 
as measured by swelling. The three aspects of the immune response 
(humoral, cellular, and phagocytic ability) were thus determined for the 
same SI line chickens. Ir-GAT* chickens were significantly higher in 
their response to both bacterins. Response to MG vaccine was also higher 
in the b' chickens compared to the B^' chickens. Phagocytic ability showed 
significant differences within sex. Roosters differed by blood type (Ea-
B) and hens differed by Ir-GAT type. The response to PHA was also 
significantly different by sex. The blood type and the RSV type 
(regressor or progressor, based on response to RSV-induced tumor 
development) were significant sources of variation in the response of 
tested roosters. Roosters of the B^ blood type responded higher and so 
did chickens of the RSV progressor phenotype. Neither of these effects 
were significant in the hens tested by PHA injection. The complexity of 
the underlying mechanisms of the immune system makes explanation 
difficult, but sex differences for other immune responses have been 
reported. For example, wattle reaction to injection with Staphylococcus 
aureus antigen differs by sex (Cotter et al. 1987). 
An additional measurement of immunocompetence was assayed in the SI 
line by Knudtson et al. (1990). Interleukin 2 (IL-2, also known as T Cell 
Growth Factor) is produced by T cells in response to exposure to antigen. 
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mitogen, or IL-2 itself. In general, IL-2 enhances activity of immune 
cells through induction of proliferation of effector cells (Farrar et al. 
1982). Concanavalin A (Con-A, a mitogen) was used in vitro to induce 
peripheral blood lymphocytes to secrete IL-2 into their culture medium. 
The resulting medium was then assayed for IL-2 activity in vitro with 
responder cells. In this case, IL-2 production was associated with Ea-B 
type of the producer cell and Ir-GAT type had no significant effect. 
Con-A-induced IL-2 production was higher for cells from haplotype 
chickens. 
Many of the studies using SI line chickens have demonstrated the 
importance of Ir-GAT as an additional genetic marker for disease 
resistance ability or immunological response traits. Studies using 
commercial lines of chickens (unrelated to the SI line) have shown that 
selection for Ir-GAT does not effect performance traits (Pevzner et al. 
1989a), but the Ir-GAT" chickens are more resistant to RSV-induced tumors, 
Marek's disease, and Staphylococcus aureus infections (Pevzner et al. 
1989). The original paper (Pevzner et a/. 1978) reported that Ir-GAT was 
distinct from the serologically detectable MHC subregions [B-F/B-G) in the 
SI line. By analogy to other species, Ir-GAT would be contained within 
the chicken MHC. However, it had never been definitively shown that Ir-
GAT is within the chicken MHC. Despite intensive investigations, there 
has never been any serological evidence of recombination resulting in a 
different Class II protein being expressed on the surface of Class II-
positive cells that would account for the GAT response differences seen in 
the SI line. Reciprocal immunizations with class II positive cells 
16 
between high and low responder chickens have never resulted in an 
alloantiserum that discriminates between Ir-GAT haplotypes. 
Pitkovski et al. (1989) attempted to detect evidence of chromosomal 
recombination between Ea-B and Ir-GAT in the SI line through the analysis 
of restriction fragment length polymorphisms (RFLP). DNA from the SI 
sublines was digested with restriction endonucleases and electrophoresed 
on agarose gels. After transfer to nitrocellulose, the resulting blots 
were hybridized with a ^^P-labelled Class II genomic probe (234 base pairs 
of the ^ 2 exon of the chicken class II gene, Bourlet et al. 1988). 
RFLP generated by 15 different enzymes failed to produce any 
patterns that could be associated with Ir-GAT. RFLP, generated by three 
enzymes of ten tested, were associated with Ea-B. Response to RSV 
challenge was not associated with RFLP. Three reasons for the lack of Ir-
GAT association with RFLP were possible. The choice of enzymes may have 
excluded the polymorphic locus or loci, Ir-GAT is outside of the MHC, or 
control of Immune response to GAT is mediated through the class II B-L a 
chain or the class I B-F molecule. Lack of association of Ir-6AT with 
class I genes was seen when SI line DNA was examined with a class I {B-F} 
gene probe (Chen and Lamont 1991). 
Antigen-Specific Immune Response Leading to Antibody Production 
Figure 1 presents a schematic flow chart of the series of reactions 
that occur prior to antibody production in response to an antigen (based 
on Marrack and Kappler 1986). Antigen is phagocytosed by the antigen-
presenting cell (APC, usually a macrophage), processed or digested into 
Figure 1. Accessory cell and interleukin-mediated interactions in an 
immune response leading to antibody production 
Ag, antigen; APC, antigen presenting cell; IL-1, interleukin 
1; IL-2, interleukin 2 (T Cell Growth Factor); IL-4, 
interleukin 4 (B cell Stimulating Factor-1); MHC, major 
histocompatibility complex; CD8, cell surface differentiation 
molecule on cytotoxic/suppressor T cells; CD4, cell surface 
differentiation molecule on helper T cells. 
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smaller pieces, and expressed on the cell surface in association with 
autologous class I or class II MHC molecules. MHC restriction is the 
requirement for identity between Class I or Class II alloantigens on 
immune cells for cooperation to occur. MHC restriction of chicken immune 
cells has been demonstrated for interaction between T cells and B cells, 
as well as the reactions between T cells and antigen presenting cells 
(APC) (Vainio et al. 1983, Vainio et al. 1988). 
Antigen processing and presentation 
T lymphocytes react to most protein antigens, not in native form, 
but after antigen has been processed within phagocytic cells and re-
expressed on the surface of the cell in association with Class I or Class 
II MHC proteins (Vainio and Lassila 1989, MacDonald and Nabholz 1986). 
Antigen processing and presentation is in large the function of the 
macrophages (reviewed by Unanue 1984) due to their ability to express 
class I and class II MHC molecules, process antigen (ingest and re-express 
on the cell surface), and to produce interleukin-1 (a monokine that 
augments T cell proliferative response to antigen or mitogen). There is 
some debate over the identity of the principal APC in vivo and whether B 
cells or monocyte/macrophages are more prominent (Ashwell 1988, Kurt-Jones 
et al. 1988). Work conducted with chickens has indicated that B cells are 
unable to activate resting T cells in vivo until antigen presenting non-B 
cells provide a triggering signal (Lassila et al. 1988, DeFranco 1988). 
The APC presents the processed antigen to the two major subsets of T 
lymphocytes, the CD4* cells and the CD8* cells (for a review of T cell 
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activation, see MacOonaTd and Nabholz 1986). 
T cell subsets 
There are subsets of T lymphocytes based on their functional 
capabilities and on differentiation proteins expressed on their membrane 
surface. Mature peripheral T cells are divisible into two distinct 
populations. One set of cells expresses the CDS receptor and the other 
expresses the CD4 receptor and their existence on mature cells is mutually 
exclusive (Chan et a/. 1988, Littman 1987). CD refers to "cluster of 
differentiation". CD4 and CD8 are transiently expressed together on 
thymocytes as part of the maturation process of T cells (Littman 1987, 
Bierer et al. 1989). 
CD4 is a phenotypic marker on helper T cells, as well as T 
lymphocytes involved in delayed-type hypersensitivity. Monoclonal 
antibodies have been developed that identify CD4 on chicken lymphocytes 
(Chan et al. 1988, Lillehoj et al. 1988). Lymphocytes treated with anti-
CD4 and complement and subsequently cultured lose their ability produce 
IL-2 upon exposure to pokeweed mitogen in vitro. This confirms that the 
antibodies identify T helper cells, because the function of T cells of the 
helper type are to produce IL-2 upon exposure to antigen or mitogen to 
augment immune response. 
The second population of T lymphocytes have the CD8 receptor on 
their cell surface. CD8 positive cells are cytotoxic or suppressor in 
function. When chicken lymphocytes are treated with anti-CD8 antibody and 
complement cytolytic activity induced toward allogeneic or 
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reticuloendotheliosis virus transformed target cells Is reduced (Chan et 
al. 1988, Lillehoj et al. 1988). 
The functional classification of T cells by CD markers may not be 
absolute. There are examples of CD4* cells that are cytotoxic and CD8* 
cells that secrete IL-2 in vitro (Bierer et al. 1989). Apparently CD4 or 
COB participates in antigen recognition by Increasing the affinity that 
the T cell antigen receptor has for presented antigen. The main immune 
function of CD4 and COB molecules may be to serve as co-recognition 
markers by directly interacting with class I or class II, respectively, on 
the APC (Bierer et al. 1989). 
The CDB* T cells recognize antigen presented in association with 
class I MHC molecules through the antigen specific T cell receptor (Tcr) 
and physically bind to the APC. The CD4* T cells bind to APC that express 
antigen in association with autologous class II MHC molecules. The 
binding of the T cells induces the macrophage to secrete IL-1. The IL-1 
in turn results in the clonal expansion and differentiation of the T cells 
that have bound to the presented antigen and are now referred to as 
activated cells. Antigen presentation to the CD4* T cells results in the 
increased synthesis of IL-2 and IL-2 receptor by these cells. The IL-2 
results in additional proliferation of antigen-specific CD4* and CD8* 
cells. 
The activated CDB* T cells expand in number and differentiate into 
functional cells. Some activated CD8* T cells are functionally cytotoxic 
and will destroy cells bearing autologous class I MHC molecules and the 
antigen fragment their Tcr recognizes. These cells especially contribute 
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to immune surveillance of virus- or cancer-transformed cells (Nabholz and 
MacDonald 1983). CD8* T cells are also involved in antigen-specific 
suppressor activity through mechanisms that are not well defined or widely 
accepted (Green et  a l .  1983).  
Simultaneously with T cell activation, B cell activation is 
occurring. The B cells interact with free antigen through their antigen-
specific receptor (surface bound immunoglobulin). The antigen is bound by 
the immunoglobulin and engulfed by the cell. The endocytosed complex is 
digested, and subsequently, pieces of the antigen are expressed on the 
cell surface in association with class II MHC molecules. The activated 
helper T cells (CD4*) that can recognize the presented antigen (through 
their Tcr) bind to the B cells. The bound T cells in turn release IL-4 
which starts the clonal expansion and differentiation of the B cells into 
immunoglobulin-secreting plasma cells (Paul and Ohara 1987). At least two 
other interleukins (IL-5 and IL-6) contribute to the complete development 
of the plasma cells (Kishimoto and Hirano 1988). 
A great amount of chicken T cell functional characterization took 
place before the development of antibodies capable of defining T lympho­
cyte subsets (for a review see: Chi and Thorbecke 1987). Monoclonal 
antibodies that can identify avian CD4 and CD8 have recently been devel­
oped by two research groups (Chan et ah 1988, Lillehoj et al. 1988). The 
availability of these monoclonal antibodies has made it possible to 
explore the nature of cells involved in antigen-specific reactions in 
chickens. 
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The Nature of Immunologic Non-response 
It is possible that the humoral immune response to GAT is mediated 
at some other level of cell interaction or by cell surface proteins other 
than la (B-L). For example, the T cell's contributions to immune 
response or antigen presentation (both subject to MHC restriction) could 
be determining factors. There is evidence for non-response to antigen 
(measured as antibody production) being primarily a T-cell mediated 
phenomena (Janeway 1983) and mechanisms of disease resistance in chickens, 
though poorly understood, require T lymphocyte involvement (Lillehoj 
1991). 
Janeway (1983) proposed three generalized hypotheses to account for 
non-response to antigen: 
1. Failure of the antigen to interact with la molecule (really an 
antigen presentation defect). 
This is usually due to MHC haplotype differences. There are some I  
region haplotypes that fail to interact with antigen. 
2. Absence of T cells (or particular T cell subpopulations) that can 
interact with the la-antigen complex on the APC. 
Absence of reactive T lymphocytes could be due to the maturation 
process in the thymus (auto-reactive thymocytes are clonally eliminated) 
or the existence of natural tolerance (Von Boemer et al. 1978). 
3. Induction of antigen-specific suppressor T cells. 
In the mouse, low or non-response to GAT is mediated through the T 
cells and is seen as a dominance of suppression over help for immune cells 
(Gershon et al. 1983, Pierce et al. 1988). Pierce et al. were able to 
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demonstrate the induction of T-cell populations that were specific for the 
antigen (GAT) and had the suppressor phenotypic marker (CD8). Antigen-
specific activation of suppressor T cell populations does not universally 
mediate low response. It has not been possible to demonstrate suppressor 
T cell involvement in mice that are non-responders to pigeon cytochrome c 
(Schwartz et al. 1985). 
There are examples that indicate that non-responsiveness is not 
always due to T cell deficiencies (Herber-Katz et aJ. 1983, Adorini and 
Doria 1981). Janeway favored the hypothesis that non-response was due to 
antigen processing defects, but only if induction of antigen-specific 
suppressor cells could not be demonstrated. 
Adorini and Doria (1983) found that "Biozzi" mice, genetically 
selected for low antibody response to sheep red blood cells, were also low 
responders to secondary challenge with hen egg white lysozyme (HEL), as 
measured by T cell proliferation in vitro. However, when the secondary 
HEL stimulation in vitro was increased in concentration 50 times, the low 
responder cells proliferated to a degree similar to high responder cells. 
This suggested that low responder cells had HEL antigen receptor and that 
antigen presentation was impaired or defective in some way. It was 
proposed that the catabolic activity of the low responder macrophages 
overprocessed the HEL and subsequently expressed antigen on the macrophage 
surface that was not recognizable by the T cells. The 50-fold increase of 
antigen in vitro overwhelmed the macrophages and resulted in the 
expression of a less processed antigen that was capable of stimulating the 
T cells. Mouton et al. (1984), using the same mouse lines, found similar 
25 
phagocytic activity when they compared high and low responder sublines by 
carbon clearance assay. They also found evidence that antigen persisted 
longer in high responder mice. The antigen turn-over rate was faster in 
low responder mice and indirectly indicated faster catabolism. It was 
possible that the antigen was being removed before immune cell activation 
occurred. 
The ability to produce antibody is the end result of a chain of 
reactions involving different cells and soluble mediators. The humoral 
immune response to GAT has been linked to important immunological traits 
as well as disease resistance, but the underlying mechanisms are poorly 
understood. The purpose of the research presented in this dissertation 
was to investigate some of the reactions, presumably mediated through 
different immune effector cells, that contribute to antibody production to 
GAT in the SI line of chickens. Most of the reactions were studied in  
vitro to dissect the appropriate cells that participate in the immune 
reaction. 
MATERIALS AND METHODS 
Experimental Animal s 
All chickens used in these studies were produced and housed at the 
Iowa State University Poultry Research Center. Chickens were housed in 
conventional floor pens or wire cages and received food and water ad 
libitum. All chickens received vaccinations for Marek's disease and fowl 
pox. The SI line chickens (described in the Literature Review) are 
maintained from generation to generation by mating five males of each 
subline to approximately five hens (per male) of the same subline by 
artificial insemination. Breeders were selected to represent the 
appropriate Ea-B and Ir-6AT types. Ten to 20% of the progeny in each 
generation were selected as breeders. The inbreeding coefficients of 
these sublines averaged .40 in 1985 (Cheng et al. 1985). 
Chickens of the highly inbred (greater than 95%, Knudtson 1987) GHs 
line were used in some phases of research. The MHC haplotypes and B^' 
are maintained as sublines in this line and the sublines can be considered 
congenic. The GHs line has been widely used in immunogenetic studies and 
is referred to as G-Bl and G-B2 (B" and B' respectively) by other 
laboratories (Miggiano et al. 1976, Pink and Miggiano 1977, Morrow and 
Abplanalp 1981, Maccubbin and Schierman 1986). 
Complementation matinos 
Two types of crosses were made to test for evidence of gene 
complementation between low responder sublines. The first cross was 
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between B^' I r -GAf-  and b' I r -GAT*-  chickens of the SI line. The second 
type of cross was between SI line B^' Ir-GAT^ chickens and GHs line B^^ 
chickens (also low responders to GAT challenge). Progeny from the crosses 
were challenged with GAT at 12 weeks of age and the immune sera were 
assayed by GAT radioimmunoassay (RIA). 
Backcrosses to parental sublines and in ter  se matings were made with 
the GHs X SI F, chickens produced. These progeny were MHC typed {B-F/B-G} 
by hemagglutination at six weeks and challenged for GAT response at twelve 
weeks of age. 
GAT Immunization Challenge 
The random linear amino acid polymer GAT (L-glutamic acid^-L-
alanine^°-L-tyrosine^°) was obtained from Miles Scientific (Naperville, 
IL). All work was completed with material from the same lot number 
(3/19). On day one of the protocol, each chicken (12 to 16 weeks of age) 
was intramuscularly immunized with 1 ml total volume of antigen emulsion. 
The emulsion was 1 part complete Freund's adjuvant (Gibco Laboratories, 
Grand Island, NY); 1 part GAT in phosphate buffered saline (PBS: 0.5 M 
phosphate, 0.85% NaCl, pH 7.2), 0.5 ml in each side of the breast. Total 
dose of antigen was 250 iig. On day 21 a second dose (0.5 ml of 500 ng 
GAT/ml in PBS pH 7.2) was administered intravenously. The chickens were 
bled on day 14 (primary response) and day 28 (secondary response) and the 
sera were collected and frozen until assayed. 
28 
Radiolabellina of GAT 
GAT was labelled with (Na^^^I, IMS.300, Amersham Corporation, 
Arlington Heights, IL) by the chloram1ne-T method (Hunter 1973). Briefly, 
250 ng GAT in 0.5 ml of phosphate buffer (10 mM NaHgPO^.HgO, 40 mM 
NagHPO^'ZHgO pH 7.5) was placed in a 5-ml beaker on ice on a magnetic 
shaker. One mCi of ^ ^®I (IMS.300 is packaged as virtually no volume, PBS 
was added to the vial to facilitate removing 1 mCi) was added to the GAT 
solution, followed by 0.1 ml of chloramine-T solution (7 mM chloramine-T 
in phosphate buffer, pH 7.5). The reaction was allowed to proceed with 
stirring for five minutes. After 5 minutes, 0.1 ml of sodium meta-
bisulfite solution (10.5 mM Na^SgOg in phosphate buffer, pH 7.5) was added 
to the reaction mixture. After 3 minutes of additional stirring, 0.1 ml 
of potassium iodide solution (6 mM KI in phosphate buffer, pH 7.5) was 
added. Free ^^^I was separated from the labelled GAT by size exclusion 
chromatography over a 35 mm X 8 mm Sephadex G-50-150 (Sigma Chemical 
Company, St Louis, MO) column using a phosphate buffer mobile phase. One 
ml fractions were collected and 20 /xl aliquots from each were counted on a 
gamma counter. The first peak was the ^^®I labelled GAT and the second 
peak was free The labelled fraction with the highest counts per 
minute was kept as frozen aliquots and used for the radioimmunoassays 
within one month of labelling. 
GAT radioimmunoassav 
A modified Farr radioimmunoassay (Bluestein et al .  1971) was used to 
determine antigen binding by immune serum. The labelled GAT was diluted 
1:1000 in assay buffer (PBS pH 7.2 with 1% normal chicken serum). 
Antisera were diluted 1:10 in assay buffer. Normal chicken serum (NCS) 
was diluted and used for positive and negative controls. For the assay, 
25 111 of the labelled GAT dilution was mixed with 25 jul of the antiserum 
dilution in a 1.5 ml microcentrifuge tube. The primary reaction was 
allowed to incubate for one hour at 4* C. After the incubation, 50 pi of 
rabbit anti-chicken IgG (prepared in-house) was added to the samples and 
the negative control (NCS) tubes. Positive control tubes (antigen plus 
NCS) received 50 /il of 20% trichloroacetic acid (TCA). TCA precipitates 
all the protein, Including the labelled GAT, but free remains in the 
supernatant. The samples were incubated for an additional hour at 4' C. 
Following the second incubation, the samples were centrifuged (10 minutes 
in a microcentrifuge) and a 50 /il sample of supernatant was removed for 
assay on a gamma counter. Results were expressed as the percentage 
labelled antigen bound by the Immune serum dilution using the following 
formula: 
The immunization schedule used by Crone et  a l .  (1981) to produce B-L 
allo-antisera was used in producing anti-B-L antibody in the SI line 
through reciprocal immunizations between GAT high and GAT low responder 
chickens. A pre-immune sample was collected from all recipients (16-20 
week old chickens) before immunizations were started. On day one of the 
schedule, all recipients received 8 X 10® splenic lymphocytes intra­
% Bound 00 - fExp. sample count - TCA sample count1 XlOO 
(NCS sample count - TCA sample count) 
Protocol to Raise and Test B-L Allo-antisera 
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venously in 0.5 ml of phosphate buffered saline (PBS: 0.5 M phosphate, 
0.85% NaCl, pH 7.2). These cells were administered on the same day as 
collected from adult SI chickens and were isolated by centrifugation over 
Histopaque 1077 (Sigma) density gradient. Additional doses (5 X 10°) of 
fixed cells [isolated cells were fixed in 0.25% glutaraldehyde in PBS for 
10 minutes, washed three times in PBS with 5% fetal calf serum (PCS, 
Sigma), and stored at 4* C in PBS with 5% PCS and 0.1% NaN^] were 
administered on days 7, 14, and 21. Immune sera were collected on days 9, 
17, 24, and 28 and were frozen until assayed, which was within six months. 
Radiolabellinq of cells 
The antibodies were tested for reactivity by several methods. The 
first type was by immunoprecipitation of radiolabelled B-L positive cells. 
The cells were labelled one of two ways. Radiolabelling with Na'^^I 
(Amersham) was carried out by lactoperoxidase-catalyzed reaction (Lambris 
and Papamichail 1980, Vitetta et al. 1971). Briefly, isolated splenic 
lymphocytes (1-2 X 10®) were suspended in 1 ml of PBS containing 1 mCi of 
and 200 ng of lactoperoxidase (Sigma). The reaction was started by 
the addition of 50 ^ 1 of a 0.03% solution of HgOg. Three additional 
aliquots of HgOg were added at 2% minute intervals. The reaction was 
stopped by the addition of 10 ml of cold (4* C) PBS. After four washes in 
PBS, the cells were ready for lysis to isolate cell membranes. 
Alternatively, some cells were biosynthetically labelled with ^®S-
methionine in a procedure adapted from Guillemot et al. (1986) and Charron 
et al. (1983). Splenic lymphocytes were aseptically collected, washed 
f 
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three times, and placed in culture in Dulbecco's modified Eagle's medium 
without methionine (DMEM, Gibco Laboratories, Grand Island, NY) 
supplemented with 10% dialyzed (against PBS) PCS, 300 pg/ml L-glutamine, 
100 U/ml penicillin, and 100 pg/ml streptomycin (all supplements from 
Sigma). The cultures were incubated for one hour and then pulsed with 250 
/iCi of '®S-methionine (Amersham) for four to five hours in a 41" C under 
5% CO2 in a humidified incubator. Labeling was stopped by the addition of 
cold (4* C) PBS. The cells were washed three times in PBS and were ready 
for preparation of membrane lysates. 
Preparation of cell membrane Ivsates 
Cell membrane lysates were prepared as follows. -labelled cells 
were lysed in a buffer described by Bumstead and Curtis (1986). First, 
the labelled lymphocytes were centrifuged and the supernatant removed. 
The pellet of cells was resuspended in 1.0 ml of NP-40/deoxycholate lysis 
buffer (0.5% Nonidet P-40, 0.5% sodium deoxycholate, 0.01% phenylmethyl-
sulfonylfluoride in PBS pH 7.2). The suspension was gently shaken for one 
hour at room temperature. After lysis had occurred, the unsolubilized 
material was separated by centrifugation (10,000 X g for 10 minutes). The 
supernatant was removed and frozen (-4* C) until analyzed by immuno-
precipitation and gradient polyacrylamide gel electrophoresis (PAGE) 
within two weeks. 
Cells labelled biosynthetically were lysed in Tris-buffered saline 
(50 mM Tris pH 7.0, 150 mM NaCl, and 0.02% NaN,) containing 0.5% NP-40. 
The cells were incubated in the Tris lysis buffer for 15 minutes at 4*C 
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and then centrifuged for 30 minutes (10,000 X g, 4'C). The supernatant 
was collected and used immediately for immunoprecipitations. 
ImmunooreciDitatibn reaction 
Cell lysates were pre-cleared by incubation with either formalin 
fixed Staphylococcus aureus cells or protein A-coated Sepharose beads 
(Pharmacia LKB Biotechnology Inc., Piscataway, NJ) to remove material that 
would react non-specifically prior to the immunoprecipitation reaction. 
The membrane lysate from 1 X 10^ cells was reacted with 100-200 /il of 
antiserum for 4-8 hours at 4*C on a shaker. This reaction formed the 
primary immune complex which was then precipitated by the addition of 
rabbit anti-chicken IgG and protein A-Sepharose. The primary immune 
complex was bound to the Sepharose and collected by centrifugation (10 
minutes, 10,000 X g). The complex-Sepharose was washed three times in NP-
40/deoxycholate lysis buffer and eluted by boiling for 10 minutes in 50-
100 ffl sample buffer (0.125 M Tris pH 6.8, 4% sodium dodecylsulfate (SDS), 
20% glycerol, 0.1 M dithiothreitol, and 0.05% bromophenol blue). The 
eluted complex was then ready for electrophoresis on gradient gels. 
Polvacrvlamide ael electrophoresis 
Gradient polyacrylamide slab gels were prepared as describe by Hames 
(1981) using the concentrations described by Laemmli (1970). The gradient 
ran from 5% to 15% acrylamide with a 3.75% discontinuous stacking gel. 
Samples (10-40 nl) were added to the wells and electrophoresed at 25 mA 
constant current until the tracking dye reached the bottom of the gel 
33 
(usually 2.5 to 3 hours). After removal from the gel cassette, the gels 
were dried onto a piece of filter paper on a gel drier. The dried gels 
were used to expose x-ray film for autoradiograms. 
Western blot analysis of antisera 
Antisera were also assayed by Western or immuno-blotting using the 
procedures reported by Bumstead and Curtis (1986). Briefly, unlabelled 
cell lysates (prepared the same as labelled cell lysates) were prepared 
for electrophoresis by boiling 10-25 of lysate with an equal volume of 
sample buffer (0.125 M Tris pH 6.8, 4% SDS, 20% glycerol, 0.1 M dithio-
threitol, 0.05% bromophenol blue) for 10 minutes. The sample was then 
transferred to the well of a polyacrylamide gel and electrophoresed. 
After electrophoresis, the gel was removed and the separated proteins were 
transferred to nitrocellulose by electro-transfer (30 V, constant, for 8-
12 hours). After transfer, the open reactive sites on the nitrocellulose 
were blocked by incubating the blot in PBS-Tween (PBS pH 7.2 with 5% 
Tween-20) for at least 1 hour at room temperature. The blot was then 
incubated with the primary chicken antibody (used at dilutions of 1:50 to 
1:100) in PBS-Tween for at least 4 hours at room temperature. After the 
first incubation, the blot was washed in PBS-Tween and incubated with the 
second antibody [biotinylated-rabbit anti-chicken IgG (Zymed Laboratories, 
South San Francisco, CA)], diluted 1:1000 in PBS-Tween. After a 2-3 hour 
incubation at room temperature, the blot was again washed and a 1:2500 
dilution of streptavidin-alkaline phosphatase (Zymed) was added to the 
blot for 2 hours at room temperature. After the last incubation, the blot 
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was washed in PBS-Tween and BCIP/NBT substrate (5-bromo-4-chloro-3-
indolyl-phosphate/nitro blue tetrazolium chloride, available as a kit from 
Zymed) was added and the color reaction was allowed to develop. Develop­
ment was stopped by washing the blot in distilled water. 
Antigen-induced In  Vi t ro Proliferation Assay 
In  v i t ro proliferation of T lymphocytes induced by GAT was assayed 
by a procedure modified from Vainio et al. (1988). Blood was collected by 
heparinized syringe from the jugular vein of chickens primed by GAT 
immunization (250 fig GAT in 0.5 ml PBS emulsified with 0.5 ml of complete 
Freund's adjuvant-i.m.) two weeks previously. Peripheral blood 
lymphocytes (PBL) were separated from whole blood by centrifugation over 
Histopaque 1077 (Sigma) density gradient. The lymphocyte fraction was 
collected aseptically and washed three times with culture medium (RPMI 
1640 with 25 mM HEPES (Gibco) supplemented with 100 U/ml penicillin, 100 
Hg/ ml streptomycin, 5% of heat-inactivated normal chicken serum (Sigma) 
and 5 X 10® M 2-mercaptoethanol). After the last wash, the cells were 
resuspended in the medium, counted, and the cell concentration was 
adjusted to 1 X 10^ cells/ml. 
Cell suspensions were added to sterile, flat bottom, 96-well tissue 
culture plates (Flow Laboratories, McLean, VA) (100 pl/well containing 10* 
cells). An additional 100 /fl of medium with or without antigen was added 
to each well. Final GAT concentrations of 0, 1, or 10 /xg/well were 
routinely used. Cells from each chicken were cultured with all three con­
centrations of GAT in quadruplicate. After the cultures were set up, they 
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were incubated in a humidified, 41* C, 5% COg incubator for three days. 
After three days, proliferation was measured by 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. 
MTT In  Vi t ro Proliferation Assay 
T cell proliferation in vitro was measured (as viable cells) by a 
colorimetric assay based on cleavage of MTT by living cells (Mosmann 
1983). Stock solution of MTT (10 mg/ml) was prepared in PBS, filtered 
(0.45 /wn), and stored in dark glass at 4* C until used (within two weeks). 
At the end of the culture period, 20 /il of MTT stock solution was added to 
each well of the plate. The plate was returned to the incubator for an 
additional 3 hours. At the end of incubation, 150 n^ of medium was 
removed, without disturbing the cells, from each well and replaced with 
150 /il of acid-isopropanol (3.3 ml 12 N HCl/liter of isopropanol). The 
plate was then vortexed to insure lysis of cells and to dissolve the 
cleaved MTT. Absorbance at 570 nm was determined for each well on an 
ELISA plate reader (Model ELIA Reader, Fisher Scientific Co., Itasca, IL). 
In  Vi t ro Antigen-presenting Cell Assay 
Plastic-adherent cells from Histopaque 1077 (Sigma) isolated PBL 
were used as antigen-presenting cells (APC) for in  v i t ro stimulation of in  
y/yo-primed T cells. The adherent mononuclear cells are primarily 
monocyte/macrophage cells (Chu and Dietert 1989) and were prepared by a 
method used by Vainio et a7. (1988). PBL were first isolated from whole 
blood of GAT primed-chickens by gradient centrifugation over Histopaque 
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1077. The mononuclear cell layer at the interface was collected and 
washed three times in supplemented RPMI 1640 (see Antigen-induced In  Vi t ro 
Proliferation Assay); the cell concentration was adjusted to 5 X 10* 
cells/ml. The cell dilutions were plated into a 96-well plate (200 pi 
containing lO' cells/well). The cultures were placed in an incubator 
(humidified, 41* C, 5% COg) for adherence to occur (1-2 hours). After the 
first incubation, the non-adherent cells were washed away (3X) with fresh, 
prewarmed (41* C) medium. Medium with antigen (GAT at 10 pg/well in 200 
/il) was then added to the remaining adherent cells. Negative controls 
received 200 pi of medium without antigen. The cultures were returned to 
the incubator for a 5 hour antigen pulse. During the antigen pulse, the 
responder T lymphocytes were prepared. 
Responder cells from GAT-primed chickens were isolated from whole 
blood by centrifugation over Histopaque 1077. Isolated cells were washed 
three times in medium and the cell concentration was adjusted to 5 X 10* 
cells/ml in supplemented medium. After the ARC culture had been antigen 
pulsed for five hours, the adherent cells were washed three times with 
medium (no GAT) to remove the non-internalized GAT and the prepared 
responder cell dilutions (200 pi volume) were added to them without any 
additional antigen. The cultures were returned to the incubator for a 
three-day incubation before proliferation was determined by MTT assay. 
Responder cells and ARC were combined within Ea-B type (to avoid mixed 
lymphocyte proliferative reaction) and were matched or mismatched by Jr-
GAT type. 
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Fluorescent Labelling of Cultured Cells for Flow Cytometry 
Cell surface phenotype of cells receiving secondary exposure to GAT 
in vitro was determined by fluorescent antibody labelling and analysis by 
flow cytometry. Cells cultured (as described in Antigen-induced in  v i t ro 
Proliferation Assay) with 0, 1, or 10 pg/well concentration of GAT for 
three days were collected for analysis. Non-adherent cultured cells were 
placed in siliconized 12X75 mm glass tubes and washed once in cold (4* C) 
wash buffer (I.IX Dulbecco's PBS (Sigma) plus 2% heat-inactivated fetal 
calf serum, plus 0.1% NaNj) before labelling. 
Monoclonal antibodies (as hybridoma culture supernatants) were 
obtained from two sources. Anti-CD8 was a gift from Dr. Hyun Lillehoj 
(USDA-ARS, Beltsville, MD) and was used at a dilution of 1:10 (in wash 
buffer). The anti-CD8 is a mouse monoclonal antibody which identifies 
chicken T lymphocytes of the cytotoxic/suppressor functional type 
(Lillehoj et al. 1988). An anti-CD4 monoclonal antibody (culture 
supernatant) was a gift from Dr. Chen-lo Chen (University of Alabama, 
Birmingham, AL). The anti-CD4 antibody identifies a molecule that is the 
avian homologue of the surface marker on T cells of the helper phenotype 
(Chan et ah 1988). Anti-C04 antibody was used at a dilution of 1:10. 
After one wash, the harvested cultured cells were resuspended in 100 
Ml of primary antibody dilution (anti-CD4 or anti-CD8) or wash buffer only 
(for controls). The cells were incubated for 30 minutes at 4* C. 
Following incubation, the cells were washed three times with cold wash 
buffer and the second antibody was added. 
The second antibody was fluoroisothiocyanate (FITC)-conjugated 
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rabbit anti-mouse IgG F(ab')2 fragments (Sigma) diluted 1:100 with wash 
buffer. Washed cells were resuspended in 100 /il of the second antibody 
dilution and incubated for 30 minutes at 4* C. Controls received no 
primary or secondary antibody or secondary antibody only. 
Following the second incubation, the cells were washed three times 
with cold wash buffer. After the last wash, the cells were fixed by first 
resuspending the cells in 200 /il Dulbecco's PBS (with 0.1% NaN,) and then 
adding 200 n^ of 2% paraformaldehyde (Electron Microscopy Sciences, Fort 
Washington, PA) solution (in DPBS + 0.1% NaNj). Samples were covered with 
aluminum foil and refrigerated (4* C) until analyzed by flow cytometry. 
Flow cytometry 
Labelled cells were analyzed on an EPICS Profile I flow cytometer 
(Coulter Corporation, Hialeah, FL). Lymphocyte populations were selected 
for fluorescence analysis based on forward light scatter versus side light 
scatter (size versus granularity) histograms. The analyzed lymphocyte 
populations represented an average of 84% of the cultured cells through 
the flow cytometer. The flow cytometer was electronically gated to exclude 
background fluorescence from analysis. Results were recorded as percent 
fluorescence positive cells (within gated fluorescence window) of 4 X 10^ 
cells tested. 
Statistical Analysis 
Analyses of variance were performed on assay results using the 
values from different assays as the variables and the traits of selection 
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(Ea-B, I r -GAT) as sources of variation. Differences between means were 
tested by Duncan's multiple range test or by t test (SAS Institute Inc. 
1985). 
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RESULTS 
Anti-B-L Alloantisera 
Despite the immunization of hundreds of chickens (84 by one protocol 
alone), none of the immunization protocols resulted in an antiserum that 
could discriminate between Ir-GAT" and Ir-GAT"" chickens. None of the 
screening methods used, despite their sensitivity in detecting B-G or B-F 
antigens, could detect B-L allo-antibody in serum from chickens used in 
reciprocal immunizations. Figure 2 shows the results of a Western 
(immuno) blot assay using anti-lL antiserum as the primary antibody versus 
bursal lymphocyte membrane lysates of each of the four SI haplotypes. The 
bands above 50 kd are due to cross reactivity with the streptavidin-
phosphatase conjugate used to detect the primary antibody. The bands in 
lanes 1 and 2 are the B-F protein. 
B-G antigen was also detectable by immunoblot assay. Figure 3 shows 
the results of probing B^ and b" red blood cell (RBC) membrane lysates 
with anti-B" antiserum. Arrows indicate the B-G13 protein from the B^^ 
RBC lysate. The double bands in the lanes where the sample was not 
reduced may be due to partially reduced proteins migrating separately or 
variation in the length of the cytoplasmic portion of the molecule under 
non-reduced conditions. 
GAT-induced in  v i t ro Proliferation of Antigen-primed Lymphocytes 
Two sets of chickens were used to determine if there were measurable 
differences in proliferation when lymphocytes from GAT-stimulated chickens 
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Figure 2. Western (Iinniuno)-blot of bursal lymphocyte membrane proteins 
separated by gradient polyacrylamide gel electrophoresis. 
Primary antiserum was produced by immunizing S1-19H chickens 
with splenic lymphocytes from Sl-IL chickens. Lane 1, IH 
lysate; lane 2, IL lysate; lane 3, 19H lysate; lane 4, 19L 
lysate. Arrow indicates B-F band 
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Figure 3. Western (Immuno)-blot of GHs line red blood cell (RBC). membrane 
proteins separated by gradient polyacrylamide gel 
electrophoresis. Primary antiserum was produced by immunizing 
GHs-6 chickens with GHs-13 RBC. Lane marked X contains 
molecular size standards. Lanes marked R or N contain lysates 
that were reduced (R) or non-reduced (N). Arrows indicate B-G 
bands 
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received a second stimulation in  v i t ro.  The first assay group were all 
hens and were at least one year of age. The second group of birds was of 
both sexes assayed between twelve and sixteen weeks of age. 
Table 2 shows the results for the first assay group (shown 
graphically in Figure 4). There was no difference in amount of prolifer­
ation within a haplotype among the concentrations of GAT. There were 
differences between haplotypes within a level of GAT (Table 3). In 
general, the cells from Ir-GAT" chickens proliferated more than cells from 
the Ir-GAT*". Table 4 shows the analysis of variance on absorbance at 570 
nm at each concentration of GAT used in the culture medium. At each level 
of GAT, the Ir-GAT type of the cells was a significant source of variation 
and blood group (Ea-B type) was not significant. 
Table 2. Mean MTT values (absorbance at 570 nm) ± standard error for 
cultured cells from the first assay group of chickens. 
Lymphocytes were assayed at three levels of GAT in the medium. 
Means within a column not sharing a letter are significantly 
different (P<0.05) 
GAT CONCENTRATION IN MEDIUM 
MHC 
TYPE 
N® 
0 GAT 
MTT^^SAY N" 
1 ng GAT 
MTT^^SSAY N® 
o
 
19H 10 1.360* ± .08 10 1.289* ± .08 10 1.427* ± .08 
19L 9 1.009® ± .14 9 0.965® ± .11 9 1.056® ± .14 
IH 8 1.295*® ± .09 8 1.273* ± .08 8 1.419* ± .09 
IL 8 1.012® ± .05 8 0.992® ± .06 8 1.062® ± .06 
"Number of chickens assayed. 
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Table 3. Analysis of variance of MTT values (absorbance at 570 niti) by 
concentration of GAT in the medium. Cells from chickens of the 
first assay group 
q /ig GAT/WELL 1 iig GAT/WELL 10 ng GAT/WELL 
Source df 1 MS^XIQ: df 1 MSXIQ: df 1 MSXIO: 
Haplotype 3 28.6* 3 27.0" 3 38.7* 
Error 31 8.4 31 6.0 31 8.3 
"Degrees of freedom, 
^ean square. 
P<0.05. 
Table 4. Analysis of variance by GLM of MTT values (absorbance at 570 nm) 
by concentration of GAT. Chickens from first assay group 
0 /ig GAT/WELL 1 /ig GAT/WELL 10 fig GAT/WELL 
SOURCE df 1 MS^XIO'^ df 1 MSXIO"^ df 1 MSXIO"^ 
BLOOD TYPE 1 2.7 1 2.3 1 8.3 
Ir-GAT TYPE 1 805.7* 1 7917.0* 1 1147127.4* 
BT*GAT= 1 19.1 1 40.0 1 427.6 
ERROR 31 84.5 31 604.3 31 833655.4 
^Degrees of freedom. 
'^ean square. 
'^Blood type X Ir-GAT type interaction. 
P<0.005. 
To better evaluate the lymphocyte's response to secondary GAT exposure in  
vitro, an index was constructed by dividing the mean absorbance of wells 
with GAT by the mean absorbance of the same cultures without GAT. This 
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ABSORBANCE 670 nm 
19H 19L 1H 
HAPLOTYPE 
IL 
QAT LEVEL 
•i 0 QAT ug QAT i M 10 ug QAT 
Figure 4. Raw MIT values (absorbance at 570 nm) for the first assay group 
of chickens. Each haplotype was cultured and assayed at three 
different concentrations of GAT in the medium 
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value was multiplied by 100 and the result was subtracted from 100. Thus 
index scores above 0 indicated percent proliferation above control levels 
and negative scores indicated percent suppression below control levels. 
Figure 5 shows the graph of the index scores by haplotype and GAT level 
(1 or 10 /xg/well). Within each haplotype, except 19H, there was a 
significant difference in the response comparing 1 or 10 /ig of GAT. The 
lower level of GAT suppressed proliferation below control values. Figure 
6 shows the results of combining absorbance values by Ir-GAT type. At 
each level of GAT, the lymphocytes from Ir-GAT" chickens proliferated in 
culture better than cells from Ir-GAT*" chickens. 
Table 5 shows the mean absorbance of the second assay group tested 
at three levels of GAT. Results are shown graphically in Figure 7. Again 
there were no differences within haplotype between concentrations of GAT. 
There were differences among haplotypes within a level of GAT (Table 6). 
The analysis of variance by GAT concentration in the medium is shown 
in Table 7. At each level of GAT, the Ea-B (blood) type of the cell donor 
was a significant source of variation, cells from B^' chickens had higher 
levels of proliferation. At the 10 jig GAT level, Ea-B type and Ir-GAT 
type of the cells was significant. At the 10 ng level, there was a 
tendency for the Ir-GAT" cells to proliferate more compared to cells from 
Ir-GAT"- chickens. Response of the cells did not vary by sex of the donor 
chicken. Figure 8 presents the results of plotting the index score by MHC 
haplotype. There were no differences in index scores among haplotypes at 
either level of GAT and the difference between GAT concentrations within 
haplotype was not significant. The 1 ng level of GAT did not result in 
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INDEX SCORE 
12| 
MHC HAPLOTYPE 
GAT LEVEL 
1 ug GAT ^ 10 ug GAT 
Figure 5. Raw MTT values converted to an index score (percent of control) 
for chickens of the first assay group. Within a haplotype, 
columns not sharing a letter are significantly different 
(P<0.05) 
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ABSORBANCE 670 nm 
1.6 
1.4 
1.2 
0.8 
0.6 
0.4 
0.2 
1 ug QAT 10 ug QAT 0 QAT 
QAT LEVEL 
QAT TYPE 
^ Ir-QAT H W Ir-QAT L 
Figure 6. Mean MTT values from the first assay group pooled by Ir-GAT 
type. Within a level of GAT, columns not sharing a letter are 
significantly different (P<0.05) 
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Table 5. Mean MTT values (absorbance at 570 nm) ± standard error for 
cultured cells from the second assay group of chickens. 
Lymphocytes were assayed at three concentrations of GAT in the 
medium. Means within a column not sharing a letter are 
significantly different (P<0.05) 
GAT CONCENTRATION IN MEDIUM 
0 GAT/WELL 1 fiq GAT/WELL 10 /ig GAT/WELL 
MHC 
TYPE 
N= MTT^^SSAY N= HH^SSAV N' MTT^^SAY 
19H 16 0.779* ± .06 16 0.808* ± .06 16 0.836* ± .06 
19L 16 0.642® ± .03 16 0.655® ± .03 16 0.683® ± .03 
IH 16 0.513® ± .04 16 0.506*= ± .04 16 0.569®'= ± .04 
IL 16 0.541® ± .05 16 0.537®": ± .04 16 
o
 
-
H u i
n o
 
^Number of chickens assayed. 
Table 6. Analysis of variance of MTT values (absorbance at 570 nm) by 
concentration of GAT in the medium. Cells from chickens of the 
second assay group 
Source 
0 ng 
df 
If C9 
1 119 
df 
GAT/WELL 
MSXIQ: 
10 IK 
df 
GAT/WELL 
MSXIO: 
Haplotype 
Error 
3 
60 
22.9* 
3.4 
3 
60 
30.2* 
3.3 
3 
60 
28.5* 
3.2 
"Degrees of freedom, 
^ean square. 
P<0.001. 
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ABSORBANCE 670 nm 
19H 19L 1H 
HAPLOTYPE 
IL 
QAT LEVEL 
H 0 QAT ^ 1 ug QAT g M 10 ug QAT 
Figure 7. Raw MTT values (absorbance at 570 nm) for the second assay 
group. Each haplotype was cultured at three concentrations of 
GAT in the medium 
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INDEX SCORE 
251 
19H 19L 1H IL 
MHC HAPLOTYPE 
QAT LEVEL 
1 ug QAT ^ 10 ug QAT 
Figure 8. Raw MTT values converted to an index score (percent of 
control). Second assay group 
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Table 7. Analysis of variance of MTT values (absorbance at 570 nm) by 
concentration of GAT for cultured cells from chickens of the 
second assay group 
0 ng GAT/WELL 1 tig GAT/WELL 10 /ig GAT/WELL 
SOURCE df MS" df MS df MS 
BLOOD TYPE 1 0.53" 1 0.71" 1 0.66" 
Ir-GAT TYPE 1 0.05 1 0.06 1 0.13* 
BT*Ir-GATb 1 0.11 1 0.14* 1 0.06 
ERROR 60 0.03 60 0.03 60 0.03 
^Degrees of freedom. 
^ean square. 
®Blood type X Ir-GAT type interaction. 
JP<0.05. 
P<0.0001. 
suppression of proliferation below control levels in this assay group. 
Figure 9 shows the results of pooling absorbance values within Ea-B type. 
At each level of GAT, the b" cells proliferated more than cells from B^ 
chickens. 
Antigen Presenting Cell Assay 
The antigen presenting cells (APC) from GAT primed chickens (all 
hens, at least one year of age) were used to set up cultures that mixed or 
matched Ir-GAT type of antigen presenting cells with Ir-GAT type of 
responder lymphocytes. The APC were pulsed at a GAT level of 10 pg/well 
and compared to control wells of APC that were not exposed to GAT. Assays 
were conducted within Ea-B type to avoid mixed lymphocyte reactions. 
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ABSORBANCE 670 nm 
0 GAT 1 ug GAT 10 ug GAT 
GAT LEVEL/WELL 
BLOOD TYPE 
• B19 ^ B1 
Figure 9. Mean MTT values from the second assay group pooled by blood 
type. Within a level of GAT, columns not sharing a letter 
represent means that are significantly different (P<0.05) 
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Table 8. Mean MTT index scores ± standard error for the eight 
different combinations of antigen presenting cells (APC) with 
responder cells 
APC TYPE RESPONDER 
TYPE 
N" MEAN MTT 
SCORE 
IH IH 27 -2.1 ± 1.2 
IH IL 9 -3.8 ± 2.9 
IL IH 9 3.6 ± 1.6 
IL IL 3 6.6 ± 2.3 
19H 19H 14 -1.5 ± 1.1 
19H I9L 9 -2.4 ± 1.1 
19L 19H 14 0.1 ± 2.4 
19L 19L 9 1.7 ± 1.9 
"Number of cultures assayed in triplicate. 
Table 8 presents the mean MTT index scores (percent of control, the same 
combination of cells without GAT pulse in vitro) for the eight types of 
cultures assayed. Number of cultures varied due to the number of chickens 
available and their GAT response phenotype. Table 9 is the analysis of 
variance within Ea-B type based on the MTT index scores. Within the 
blood group, the Ir-GAT type of the APC was a significant source of 
variation. The Ir-GAT type of the APC within the B^' blood type was not 
significant. The responder cell Ir-GAT type was not significant within 
either blood group. Figure 10 shows the mean index scores by responder 
cell Ir-GAT type within the B^ blood group. Figure 11 shows the results 
within the B^' blood group. None of the MTT means were significantly 
different for cultures within the B^' blood group, but the trend was the 
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Table 9. Analyses of variance of MTT index scores for antigen presenting 
cell (APC) and responder cell cultures mixed or matched by 
Ir-GAT type 
WITHIN B1 BLOOD GROUP: 
SOURCE df MEAN SQUARE 
APC GAT TYPE 1 202.5* 
RESPONDER GAT 1 16.6 
APC*RESPONDER GAT 1 100.5 
ERROR 45 44.1 
WITHIN 819 BLOOD GROUP: 
SOURCE df MEAN SQUARE 
APC GAT TYPE 1 68.7 
RESPONDER GAT 1 52.1 
APC*RESPONDER GAT 1 96.2 
ERROR 43 34.7 
"Degrees of freedom. 
P<0.05. 
same as for the results in the B^ blood group. There was a tendency for 
the Ir-GAT*" APC to present antigen better than the Ir-GAT" APC. 
Cell Surface Phenotype of Cultured Cells 
Lymphocytes from the second assay group were also characterized for 
cell surface phenotype (CD4 and CDS) by immunofluorescent labelling and 
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INDEX SCORE 
n 
1H IL 
APC Ir-QAT TYPE 
RESPONDER GAT TYPE 
^ Ir-QAT H W Ir-QAT L 
Figure 10. Mean MTT index scores within the B blood group. The B 
antigen-presenting cells (APC) resulted in a higher mean score 
than the B APC regardless of responder cell type 
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Figure 11. 
INDEX SCORE 
V777 
19H 19L 
APC Ir-QAT TYPE 
RESPONDER QAT TYPE 
Ir-QAT H W Ir-QAT L 
Mean MTT index scores within the B blood group. There was 
no significant difference between means based on Ir-GAT type 
of the antigen-presenting cells (APC) or the responder 
lymphocytes 
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flow cytometry. Cells cultured for three days at three different concen­
trations of GAT were labeled with monoclonal antibodies that reacted with 
CD4 (T helper cells) or CDS (T suppressor/cytotoxic cells). Table 10 
shows the mean percent CD4-positive cells for the SI haplotypes at three 
concentrations of GAT in the medium. Figure 12 presents the data graphic­
ally. There were no differences within a haplotype by level of GAT. 
Within each level of GAT there were differences by haplotype (Table 11). 
At each GAT concentration in the medium, blood type of the donors was a 
significant source of variation (P<0.02). Sex and Ir-GAT type were not 
significant (Table 12). 
Table 10. CD4 positive cells (percent ± standard error) for each of the 
four SI haplotypes cultured at three levels of GAT. Means 
within a column not sharing a letter are significantly 
different (P<0.05) 
GAT CONCENTRATION IN MEDIUM 
0 GAT 1 /ig GAT 10 /Jig GAT 
MHC 
TYPE 
N® % CD4* 
LYMPHOCYTES 
N" % CD4* 
LYMPHOCYTES 
N" % CD4+ 
LYMPHOCYTES 
19H a 49.2* ± 5.3 8 52.6* ± 3.9 8 50.4* ± 4.0 
19L a 47.6* ±4.1 8 48.9* ± 3.9 a 49.2* ± 3.6 
IH a 31.5® ± 2.8 7 36.0® ± 2.5 8 32.4= ± 2.7 
IL 8 40.5*®± 5.0 8 44.0*®± 4.9 8 44.0* ± 4.6 
"Number of each haplotype assayed. 
59 
Table 11. Analysis of variance by concentration of GAT in the medium for 
percent CD4-positive cells 
0 jug GAT/WELL 1 /ig GAT/WELL 10 ^ g GAT/WELL 
Source df MS" df MS df MS 
Haplotype 3 520.1* 3 381.0* 3 539.5* 
Error 28 155.7 27 122.6 28 115.8 
^Degrees of freedom, 
^ean square. 
P<0.05. 
Table 12. Analysis of variance by GAT concentration in the medium for 
percent CD4-positive cells 
0 ng GAT/WELL 1 /ig GAT/WELL 10 pg GAT/WELL 
SOURCE df MS" df MS df MS 
SEX 1 0.1117 1 21.0 1 10.1 
BLOOD TYPE 1 1113.3* 1 864.8* 1 905.0* 
Ir-GAT TYPE 1 101.4 1 17.6 1 223.8 
ERROR 28 163.6 27 131.5 28 127.1 
^Degrees of freedom, 
^ean square. 
P<0.05. 
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Figure 12. Mean percent CD4-positive cells by MHC haplotype of 
lymphocytes cultured at three different concentrations of GAT. 
Flow cytometry of cells labeled with anti-CD4 antibody 
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When results are analyzed within Ea-B type there are differences 
between Ir-GAT types (Table 13 ). Figure 13 shows the mean percent CD4-
positive cells within the Ea-B type. At the 0 and 1 ng GAT levels 
there was no difference in CD4 levels between Ir-GAT" and Ir-GAT*" cells. 
At the 10 ng GAT level there is a difference in CD4 between Ir-GAT" and 
Ir-GAT*" chickens within the B^ blood group. There were higher numbers of 
CD4-positive cells from B' Ir-GAT*" chickens. 
Table 13. Analyses of variance for percent CD4-positive cells by GAT 
concentration within blood group 
WITHIN B^ BLOOD GROUP: 
SOURCE 
0 fic 
df 
GAT/WELL 
MS" 
1 
df 
GAT/WELL 
MS 
10 /X 
df 
g GAT/WELL 
MS 
SEX 
Ir-GAT TYPE 
ERROR 
1 
1 
13 
5.8 
199.3 
142.5 
1 
1 
12 
0.7 
194.1 
131.6 
1 
1 
13 
84.0 
617.8* 
117.4 
WITHIN B^' BLOOD GROUP: 
SOURCE 
0 m 
df 
GAT/WELL 
MS 
1 m 
df 
GAT/WELL 
MS 
10 n 
df 
g GAT/WELL 
MS 
SEX 
Ir-GAT TYPE 
ERROR 
1 
1 
13 
2.3 
10.4 
192.1 
1 
1 
13 
2.6 
54.8 
132.9 
1 
1 
13 
1.6 
6.0 
125.4 
"Degrees of freedom, 
^ean square. 
P<0.05. 
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% POSITIVE 
60 
40 
30 
20 
10 
0 
0 QAT 10 ug QAT 1 ug QAT 
QAT LEVEL/WELL 
Ir-QAT TYPE 
^ QAT H W QAT L 
Figure 13. Mean percent CD4-positive cells within the B blood type. 
Columns within a level of GAT not sharing a letter represent 
means that are significantly different {P<0.05) 
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There was no difference in percent CD4-positive cells within the B19 Ea-B 
type (Table 13 and Figure 14) between cells of different Ir-GAT type at 
any level of GAT. Figure 15 presents the mean percent of CD4-positive 
cells in cultures pooled by Ea-B type. At the 1 and 10 ftg levels of GAT 
there are differences between means of the Ea-B^' and Ea-B^ groups. The 
lymphocytes from the B^' haplotype chickens had a higher percentage of CD4 
positive cells compared to B^ chickens. 
Results of labelling with an anti-CD8 monoclonal antibody are 
presented in Table 14 and Figure 16 as mean percent CD8-positive cells. 
Within a haplotype the means were not different by level of GAT. There 
Table 14. CD8-positive cells (percent ± standard error) for each of the 
four SI line haplotypes cultured at three levels of GAT. 
Means within a column not sharing a letter are significantly 
different (P<0.05) 
GAT CONCENTRATION IN MEDIUM 
0 GAT 1 ng GAT 10 ng GAT 
MHC 
TYPE 
N" % CDS* 
LYMPHOCYTES 
N= % CD8+ 
LYMPHOCYTES 
N' % CD8+ 
LYMPHOCYTES 
19H 16 17.7® ± 1.3 16 17.1® ± 1.2 16 16.5® ± 1.5 
19L 16 22.7* ± 1.9 16 22.1* ± 1.5 16 22.8* ± 1.9 
IH 16 15.8® ± 1.0 15 14.8® ± 1.2 16 15.7® ± 1.0 
IL 16 15.4® ± 1.0 16 16.2® ± 0.9 16 15.6® ± 0.9 
*Number of each haplotype assayed. 
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60 
60 
40 
30 
20 
10 
0 
0 QAT 1 ug QAT 10 ug QAT 
QAT LEVEL/WELL 
Ir-QAT TYPE 
^ QAT H ra QAT L 
Figure 14. Mean percent CD4-positive cells within the B" blood group 
65 
% POSITIVE 
60 
60 
40 
30 
20 
10 
0 
0 QAT 10 ug QAT 1 ug QAT 
QAT LEVEL/WELL 
Ea-B TYPE 
 ^B19 ra B1 
Figure 15. Mean percent CD4-positive cells, results pooled within blood 
type. Columns within a level of GAT not sharing a letter 
represent means that are significantly different (P<0.05) 
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25 
20 
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10 
5 
IL 
0 
19H 19L 1H 
HAPLOTYPE 
^ 0 QAT ra 1 ug QAT ^ 10 ug GAT 
Figure 16. Mean percent CD8-positive cells by MHC haplotype of lympho­
cytes cultured at three different levels of GAT. Flow 
cytometry of cells labeled with anti-C08 antibody 
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were differences between haplotypes within a level of GAT (Table 15). The 
cells from chickens had a higher percentage of CD8 positive cells at 
each level of GAT (Table 16). At the 10 ng GAT level, Ir-GAT type of the 
cells was also significant. 
Table 15. Analysis of variance for percent CDB-positive cells for each 
concentration of GAT in the medium 
Source 
0 lig 
df® 
GAT/WELL 
MS": 
1 ng 
df 
GAT/WELL 
MS 
10 lie 
df 
GAT/WELL 
MS 
Haplotype 
Error 
3 
60 
183.0* 
30.0 
3 
60 
139.0* 
23.4 
3 
60 
190.3* 
29.7 
^Degrees of freedom, 
^ean square. 
P<0.001. 
Table 16. Analysis of variance by GAT concentration for percent CD8-
positive cells 
0 ^g GAT/WELL 1 ng GAT/WELL 10 pg GAT/WELL 
SOURCE df® 1 MS" df 1 MS df 1 MS 
SEX 1 64.6 1 67.6 1 94.5 
BLOOD TYPE 1 397.2** 1 265.1** 1 317.6* 
Ir-GAT TYPE 1 82.9 1 115.3* 1 140.4* 
ERROR 60 30.8 59 23.6 60 30.9 
^Degrees of freedom, 
^ean square. 
..P<0.05. 
P<0.001. 
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Results were separated by Ea-B type and analyzed. Figure 17 and 
Table 17 shows the results within the blood group and there were no 
differences associated with Ir-GAT type of the cells or the level of GAT. 
Figure 18 and Table 17 show the results within the blood group. At 
each concentration of GAT, lymphocytes from Ir-GAT^ chickens had higher 
numbers of CD8-positive cells. Data pooled by Ea-B type (Figure 19) 
indicated that the B^' cultures had higher levels of CDB-positive cells 
than the b' cultures, although there were no differences due to GAT level. 
Table 17. Analyses of variance for percent CD8-positive cells by GAT 
level and within blood group 
WITHIN B' BLOOD GROUP: 
0 fig GAT/WELL 1 m GAT/WELL 10 [i GAT/WELL 
SOURCE df" 1 MS" df 1 MS df 1 MS 
SEX 1 1.1 1 12.6 1 7.9 
Ir-GAT TYPE 1 1.7 1 1.3 1 0.5 
ERROR 29 29 28 17.1 29 14.1 
WITHIN B" BLOOD GROUP: 
0 /ig GAT/WELL 1 ng GAT/WELL 10 /xg GAT/WELL 
SOURCE df 1 MS df 1 MS df 1 MS 
SEX 1 106.6 1 70.2 1 123.6 
Ir-GAT TYPE 1 202.0* 1 199.0* 1 313.1* 
ERROR 29 40.9 29 28.2 29 42.9 
^Degrees of freedom, 
^ean square. 
P<0.05. 
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Figure 17. Mean percent of CD8-positive cells within the blood group 
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CULTURE CONDITIONS: QAT/WELL 
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Wl 
Figure 18. Mean percent of CD8-positive cells within the B blood type. 
Columns within a level of GAT not sharing a letter represent 
means that are significantly different {P<0.05) 
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Ea-B TYPE 
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Figure 19. Mean percent of CD8-positive cells pooled by blood type. 
Columns within a level of GAT not sharing a letter represent 
means that are significantly different (P<0.05) 
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Anti-GAT Response in Progeny From Complementation Matings 
Two types of F, crosses were made to produce progeny that could be 
assayed by GAT challenge for evidence of gene complementation. The first 
type was a within-line cross between and chickens of the SI line 
and the second type was between SI line b"*" chickens and GHs line 8^' 
chickens. Table 18 presents the means of secondary GAT radioimmunoassay 
(RIA) values for chickens of MHC haplotypes within the lines. Table 19 
presents the mean percent GAT bound by the F, progeny of the within SI 
line cross. The progeny did not differ in GAT response by haplotype of 
sire. The mean percent bound GAT of the F^ progeny was not different from 
the means of the parental sublines. 
Table 18. Mean percent GAT bound (± standard error) in radioimmunoassay 
by secondary immune sera from the parental line types. Means 
not sharing a letter are significantly different (P<0.05) 
LINE AND HAPLOTYPE N= MEAN GAT-RIA 
SI -19H 23 80.3* ± 3.4 
SI -19L 25 27.4: ± 5.6 
SI -IH 19 88.7* ± 3.3 
SI -IL 23 35.2®"= ± 6.2 
GHs -6 20 43.0® ± 3.2 
GHs -13 18 5.3» ± I.l 
"Number assayed. 
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Table 19. Mean percent GAT bound (± standard error) in radioimmunoassay 
by secondary immune sera from the F, progeny of crosses 
within the SI line 
TYPE OF F, MATING N" MEAN GAT-RIA 
Sl-IL SIRE X S1-19L DAM 40 27.1 ± 4.4 
S1-19L SIRE X Sl-IL DAM 69 18.4 ± 2.7 
"Number of progeny tested. 
Table 20 presents the percent GAT bound means for the F, progeny of 
the between line crosses. GAT response means were not significantly 
different by sire MHC haplotype. The progeny mean was significantly 
higher (P<0.05) than the mean percent GAT bound by the parental sublines. 
Table 20. Mean percent GAT bound (± standard error) in radioimmunoassay 
by secondary immune sera from the F, progeny of between line 
crosses 
TYPE OF F, MATING N" . MEAN GAT-RIA 
S1-19L SIRE X GHs-13 DAM 57 48.2 ± 3.6 
GHs-13 SIRE X S1-19L DAM 82 53.2 .± 3.4 
"Number of progeny tested. 
Progeny from the between-line crosses were backcrossed to the 
parental sublines (GHS-B" and SI-B'""), as well as mated in ter  se.  
The resulting progeny were of three different blood types (B^' homo­
zygotes, b" homozygotes, and b''/b" hétérozygotes). The Fg progeny were 
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assayed for secondary GAT response. Table 21 and figure 20 show the mean 
percent GAT bound for the three different groups. No matter from what 
type of mating they derived, the B" homozygotes produced low levels of 
antibody when challenged with GAT. 
Table 21. Mean percent GAT bound (± standard error) in radioimmunassay 
by secondary immune sera from the F, progeny by blood type. 
Means not sharing a letter are significantly different 
(P<0.05) 
BLOOD TYPE OF F, PROGENY N" MEAN GAT-RIA 
B^'/B^' 95 66.6* ± 3.2 
B^VB" 195 71.9* ± 2.5 
B"/B^' 96 4.6® ± 1.4 
"Number assayed. 
Table 22 shows the analysis of variance for GAT response by mating 
type (F, backcrossed to the S1-19L roosters or hens, F^ backcrossed to 
GHs-13 roosters or hens, and F, crossed with F,). Sire was a significant 
source of variation for GAT response of progeny from S1-19L backcrosses, 
but wasn't significant for the other two mating types. GAT response of 
progeny produced from F, X F, and F, X GHs-13 matings differed by their 
Ea-B (blood) type. Homozygous B^' progeny were significantly lower in GAT 
response than homozygous B" or heterozygous B^'/B". Sires used in 
backcrosses to the SI or GHs lines were of two blood types (B^'/B^^ from 
the F, generation and B^'/B" or B^Vb^' from the parental lines). Table 23 
shows the analysis of variance by mating type including sire Ea-B as a 
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% QAT BOUND 
801 
13/13 19/13 19/19 
PROGENY BLOOD TYPE 
Figure 20. Mean secondary GAT antibody response (percent bound) measured 
by radioimmunoassay for the Fg progeny from backcross and 
inter se matings 
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Table 22. Analysis of variance for the percent GAT bound by Fg progeny 
produced by backcrosses or inter se matings 
BACKCROSS TO 19L 
SOURCE CL
 
MS" 
SIRE 9 2972* 
PROGENY Ea-B 1 2133 
DAM(SIRE) 4 278 
ERROR: 118 990 
^Degrees of freedom. 
4lean square. 
®Error for testing DAM(SIRE) 
*P<0.01. 
P<0.0001. 
BACKCROSS TO 13 F, CROSSED TO F, 
df MS df 1 MS 
10 127 7 405 
1 207707** 2 75529" 
8 248 5 955 
105 269 113 568 
SIRE mean square. 
Table 23. Analysis of variance for percent GAT bound by Fg progeny 
BACKCROSS TO 19L BACKCROSS TO 13 
SOURCE df" 1 MS" df 1 MS 
SIRE Ea-B TYPE 1 14291** 1 88 
PROGENY Ea-B TYPE 1 4452* 1 234679*** 
ERROR 130 1009 122 258 
"Degrees of freedom, 
^ean square. 
><0.05. 
><0.001. 
P<0.0001. 
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as a source of variation. The sire Ea-B type resulted in significant 
differences in GAT response of their progeny. The progeny of B^'/B^' sires 
had higher GAT response than the progeny of b"/b" sires and the 
heterozygous progeny (B"/b") were lower than the homozygous (B^'/B^') 
progeny. 
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DISCUSSION 
Value of Ir-GAT as a Marker for Disease Resistance 
The importance of Ir-GAT as a marker for disease resistance has been 
well-investigated in the chicken. An example in the appendix of this 
dissertation presents the results of challenging SI chickens with Marek's 
disease virus (MOV). The association between high response to GAT and 
resistance to Marek's disease remained through two generations of chickens 
tested. This association was confirmed when an Fg population of chickens 
was challenged with MOV. Similar disease resistance has been seen when 
chickens unrelated to the SI line have been selected for humoral immune 
response to GAT. Pevzner et al. (1989a, 1989b) conducted a divergent 
selection experiment within two types of commercial chickens (meat and 
egg-type). After developing sublines that were low or high responders to 
GAT, the chickens were challenged with MOV, Rous sarcoma virus, or 
Staphylococcus aureus. The Ir-GAT high lines were more resistant to the 
effects of the pathogens than the low responder sublines. Equally 
important, selection for Ir-GAT did not result in any significant change 
in performance characteristics of economic value. Pevzner attributed 
response to GAT to a major immune response gene, but did not report on any 
changes in frequency of MHC haplotypes in lines under selection. 
The benefits of Ir-GAT" coupled with the MHC effects do impart some 
advantage to the survival of the chicken. Selection for disease-resistant 
MHC types is complemented by selection for high response to GAT. For 
example, incidence of Marek's disease in MDV-challenged chickens is low in 
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haplotype SI chickens and is lower still in B' chickens that are high 
responders to GAT. This effect is also seen when more susceptible 
chickens (SI-B") are challenged with MDV; that is, the Ir-GAT" within the 
blood type are more resistant to incidence of Marek's disease (Steadham et 
al. 1987). Although the results of selecting for GAT response are clear, 
the immunological mechanisms involved have not been investigated in the 
chicken and are poorly defined. This dissertation research addressed the 
mechanisms involved in the observed differences in specific antibody 
titers after chickens are challenged with GAT. 
B-L Genes As Ir-GAT Antigens 
In mammalian systems, differences in immune response can often be 
attributed to immune response (Ir) genes that are within the MHC (McDevitt 
et al. 1972). When Pevzner et al. (1978) first reported the recombination 
between Ir-GAT and Ea-B (B-F/B-G), a possible explanation was that the 
recombination was within the MHC, using the hypothesis that Ir-GAT is 
controlled by a specific Ir gene in the MHC of the chicken. 
Attempts to locate the recombination within the MHC have never 
supported this hypothesis. Extensive attempts to raise alloantisera 
(reported in this dissertation) were unsuccessful. This could be due to 
the lack of recombination within the MHC of the SI sublines but could also 
be due to the difficulty of producing antibody to B-L antigens. The 
latter is not thought to be the case, because of the rigor of the testing 
applied. Literally hundreds of chickens were immunized in attempts to 
produce B-L alloantisera. The methods used to screen the antisera became 
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increasingly more sophisticated and sensitive. These methods were able 
to detect B-G and B-F antigen differences, but never resulted in evidence 
of B-L antibody in the serum that was assayed, and thus no serological 
evidence could be provided to support the hypothesis that Ir-GAT genes 
encode MHC class II gene products. 
Recent developments in molecular genetics have enabled the direct 
investigation of the DNA for evidence of recombination. Pitkovski et al .  
(1989) used a chicken class II probe to examine the DNA of SI chickens for 
evidence of restriction fragment length polymorphism (RFLP) that could be 
associated with Ir-GAT differences. Although 15 different endonucleases 
were used to generate fragments, none of the resulting RFLP could be 
associated with Ir-GAT. Similar results have been seen when a class I 
probe is used to examine DNA from SI chickens (Chen and Lamont 1991). The 
RFLP generated are associated with Ea-B type and not Ir-GAT type. 
Pitkovski et  a l .  (1989) reported that there were three possible 
explanations that could account for the lack of RFLP associated with GAT 
response. First, the choice of endonucleases could have excluded the 
polymorphic locus. There are available commercially several hundred 
endonucleases with different restriction sites. It would not only be 
extremely expensive.to try them all, it would consume a great deal of 
time. Large stretches of DNA can be examined with a single enzyme and 
probe. The probability that a recombination would be missed when testing 
against 15 different endonucleases becomes exceedingly small. However, 
there have been instances in mice were a single nucleotide substitution 
has resulted in an amino acid substitution that resulted in a difference 
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in immune response phenotype (Brown et al .  1986). 
The second possibility Pitkovski et al .  (1989) proposed was that 
immune response to GAT was mediated by the class II a gene. While it is 
possible that B-L a may mediate immune response to GAT, it would be likely 
that the class II probe would still result in RFLP if the class II a and 
genes are in close proximity to each other in chickens as they are in 
mice (Kaufman et al. 1984). At present, there are no chicken B-L a probes 
available and there is not enough homology between mammalian class II a 
probes and chicken DNA to be able to use the mammalian probes (Guillemot 
et ah 1988). 
The third possibility proposed by Pitkovski et al .  (1989) was that 
control of immune response to GAT was outside the MHC. The boundaries of 
the chicken MHC are not firmly established. While the nucleolar organizer 
region (NOR) marks one end of the MHC, the other end has not been defined 
(Guillemot et al. 1988). It could still be possible that Ir-GAT is within 
or linked to the end of the chicken MHC that has not been identified. 
The classical explanation of immune response mediation through Ir 
genes within the MHC may not be applicable in the chicken. There are 
genes that are within the chicken MHC that are not like the traditional 
class I or class II genes seen in mammals or chickens. One of these genes 
(identified by probe C12.3) has homology to the subunit of the human 
guanine nucleotide-blnding protein (G protein) which Is not found within 
the mammalian MHC (Guillemot et al. 1989a). The G proteins function to 
transmit signals from cell surface receptors through the cell membrane and 
have been associated with transmembrane signalling in immune cells (Neer 
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and Clapham 1988, Harnett and Klaus 1988). Monocytes, neutrophils, T 
lymphocytes, and B lymphocytes undergo receptor mediated activation steps 
that Involve the G protein (Harnett and Glaus 1988). It Is not known if 
alleles exist for the p subunit gene although Guillemot et al. (1989a) 
speculated that alleles may exist and could explain differences in 
resistance to Marek's disease associated with some MHC haplotypes (it 
could also explain differences seen in mitogen activation). There are at 
least six other non-class I/class II genes found within the chicken MHC 
that have not been characterized yet (Guillemot et al. 1988). Some of 
these unidentified genes are proposed to have an effect on Immune 
reactivity. 
GAT-induced In  V i t ro  Proliferation of Antigen-primed Lymphocytes 
Measurements of in vitro reactivity of antigen (GAT)-prlmed T 
lymphocytes were undertaken to determine if there were differences in 
proliferation that could explain the differences In humoral GAT response. 
T cells play Important accessory roles In the immune response leading to 
antibody production (see Figure 1, page 18). Three different levels of 
GAT were used in the medium to stimulate lymphocytes from GAT primed 
chickens (0, 1 /ig, and 10 /xg GAT per well). Proliferation (as measured by 
MTT assay) did not differ within SI line haplotypes by level of GAT. The 
conclusions drawn from the results of assaying proliferation in  v i t ro  
indicate that T cell reactivity to GAT is not likely to be the cause of 
different antibody response in the whole animal. This Is in contrast to 
what is seen when similar experiments are conducted with mouse cells 
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(Kimoto and Fathman 1980, Gougeon and Theze 1983). 
Kimoto and Fathman (1980) used responder and non-responder lines of 
mice as sources of GAT-primed lymphocytes. Subsequent secondary 
stimulation in vitro resulted in proliferation of responder mouse cells 
above the levels seen for cells in wells without GAT. The effect could be 
seen with doses of GAT as low as 2 pg/well and increased up to levels of 
40 fig GAT/well. Cultures of chicken cells stimulated with 20 fig GAT/well 
died before proliferation could be measured (at three days). 
The differences seen in cell proliferation were not associated with 
the level of GAT in the medium. The amount of proliferation was the same 
for wells with antigen as wells without antigen. A set of cultures were 
incubated for five days (duplicate cultures were assayed after the usual 
three days) to allow more time for proliferation to occur. Results were 
inconclusive at the longer incubation time as the cells from most chickens 
died before the end of incubation and others were greatly decreased. The 
range of responses among chickens of the same MHC haplotypes were very 
wide. Individual chickens were found that proliferated well in  v i t ro  
regardless of their haplotype. There was no association with the actual 
GAT antibody response (as measured by radioimmunoassay) at the whole 
animal level and the ability of the isolated cells to proliferate in  
v i t ro .  
The limited diversity of antigenic sites on the GAT molecule, 
although useful for determining immune response differences in the whole 
animal, were likely not sufficient for stimulating cells in vitro. The 
population of cells assayed in vitro is not the complete population of 
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cells available in  v ivo.  Similar cultures of chicken cells using a 
different antigen have resulted in proliferation above control levels 
(Vainio et al. 1988). Vainio et al. used keyhole limpet hemocyanin (KLH) 
as an antigen and cells receiving secondary exposure to the antigen in  
vitro proliferated. KLH presents a more diverse set of antigenic 
determinants than GAT and would likely result in a broader population of T 
cells that could be stimulated by the antigen. The number of lymphocytes 
responding to the antigen may not be as important, however, as what 
functional type of lymphocytes are responding to the antigen. If the 
mechanisms of immune suppression were induced (as mediated by CD8-positive 
T cells), there would not necessarily be evidence of proliferation, or a 
proliferation of CD8-positive cells could result in suppressed (low) 
antibody response at the whole animal level. On the other hand, the 
helper T cell populations (bearing the CD4 phenotypic marker) that result 
in augmented immune response could also exert their effects without 
noticeable increases in cell numbers. 
The assay results might have been different if exogenous inter-
leukin 2 (IL-2) had been added to the culture medium. The IL-2 would have 
allowed longer incubation times for proliferation differences to occur and 
there is a synergistic effect when antigen and IL-2 are used to induce 
proliferation. However, the drawbacks of including IL-2 in the medium 
prevented its use in this system. At present, there is no consistent 
source of chicken IL-2 other than using conditioned medium (the medium 
that Con-A stimulated T cells have secreted IL-2 Into) and mammalian IL-2 
is not biologically active on chicken lymphocytes (Schauenstein et a7. 
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1982). Conditioned medium not only contains IL-2 but also any Con-A that 
can not be removed or inactivated and all other soluble factors secreted 
after mitogen stimulation. When conditioned medium Is used as a growth 
supplement, there Is the possibility that the Con-A becomes more Important 
In Inducing proliferation than the antigen that is In the medium. If the 
Con-A Is Inactivated totally, there Is still the possibility that the 
proliferation that is induced primarily reflects the response of the 
cultured cells to IL-2 (which can be accounted for with the proper 
controls). An additional problem is that the biological half-life of IL-2 
activity is short and therefore can vary widely in batches of conditioned 
medium. 
Antigen-Presenting Cell Assay 
There are examples in which differences in levels of antibody 
produced can be attributed to differences in the ability of antigen 
presenting cells (APC) to process and present antigen. Some lines of 
"Biozzi" mice produce low levels of antibody based on the inability of 
their APC to present antigen to responsive T cells (Adorini and Doria 
1983). The macrophages (APC) from low responder mice processed antigen so 
rapidly that when the processed antigen was expressed on the cell surface 
it was in a form that would not cause T cells to respond. The T cells 
from low responder mice could be induced to proliferate in vitro when the 
APC were exposed to large quantities of the antigen. The APC were thought 
to express a less processed antigen fragment on their surface that the T 
cells could recognize. The APC with faster catabolic rates (from low 
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responder mice) resulted in low antibody production in the whole animal. 
When lymphocytes from GAT-primed chickens were cultured with GAT 
pulsed APC from Ir-GAT high or low chickens, the APC from the Ir-GAT^ 
chickens were better able to stimulate the responder cells regardless of 
responder cell Ir-GAT type. If an antigen-presenting cell defect were 
responsible for the differences seen in humoral immune response to GAT, 
the expectation would be for the APC from Ir-GAT" to present antigen 
better than the APC from Ir-GAT*". While the deviation from expected 
results could have been due to chance or reactivity of cells toward other 
alloantigen systems on the surface of the cells, the same effects should 
have randomly influenced the responder T cells of either Ir-GAT type. For 
example, if the proliferation were due to reactivity toward alloantigens 
there would be no reason to think that the alloantigens existed in one 
subline and not the others. 
Immune reactions can be broadly divided into those that are 
primarily humoral (mediated by antibody) and reactions that are primarily 
cellular (mediated through the actions of activated cytotoxic cells). The 
in vitro APC assay is an immune reaction that is mediated by the cells 
involved and as a result may not be a reflection of the mechanisms of in  
vivo antibody production. The requirements for antigen presentation for 
humoral immune reactions (antibody production) in vivo are different than 
the requirements for stimulating T cells in vitro. Therefore, it is not 
completely unexpected that APC from Ir-GAT" birds cause lower 
proliferation of responder cells in vitro as the mechanisms involved are 
inversely related. Estimates of quantitative genetic parameters in 
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chickens selected for immune response traits have shown that the cell 
mediated and humoral mediated traits have negative or low phenotypic 
correlations (Cheng and Lamont 1991, Cheng et al. 1991). Selection for 
high antibody response would have a tendency to lower the immune reactions 
mediated by cellular mechanisms. 
Defective antigen presentation is not always the cause of low 
antibody production. Of the five different lines of "Biozzi" mice 
(selected for divergent antibody production to different antigens) tested, 
deficient antigen presentation was a likely cause of low antibody 
production in only two of the lines (Biozzi et al .  1984, Mouton et al .  
1984). Thomas and Hoffman (1982) used responder and non-responder guinea 
pigs to angiotensin to examine the role of APC in immune response. Their 
results indicated there was no evidence of defective antigen presentation. 
Their results indicated that response was likely regulated by the T cells 
involved. Clearly, choice of antigen system and experimental animal can 
result in different results. Results obtained from experiments conducted 
in  v i t ro  may not be directly comparable with the events that occur in  
vivo, but the advantages of separating the component cells of the immune 
reaction make such assays desirable. The reactions between immune cells 
are obscured in the whole animal and only the end results (such as 
antibody produced or health of the animal) can be evaluated. In the case 
of chicken response to GAT, the APC assayed in vitro do not account for 
the differences in antibody levels seen in the whole animal. 
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Phenotypic Markers on Cultured Cells 
Lack of proliferation in response to secondary antigen exposure in  
vitro may not be as significant an indicator of antibody producing 
potential as the functional type of the cells that proliferate in response 
to the antigen. For example, cell numbers would not have to increase 
significantly if all of the cells produced were antigen specific and of 
suppressor or helper functional type (bearing the CD8 or CD4 surface 
marker respectively). Gougeon and Theze (1983) were able to cause in  
vitro T cell proliferation in response to GAT in non-responder mice by 
first deleting the cell cultures of suppressor T cells. Pierce et al .  
(1988) showed that T-cell populations that were induced in GAT non-
responder mice were specific for the antigen and had the phenotypic marker 
(CD8) of suppressor cells. Non-response to GAT in mice is apparently 
mediated through antigen specific suppressor T cells. The results of 
these two experiments also provide evidence against the possibility of 
deletions in T cell populations that recognize specific antigen. . In both 
cases, T cells from non-responder mice could respond to the antigen under 
the proper conditions. 
The percentages of CD4- or CD8-positive SI chicken cells did not 
change with different levels of GAT in the culture medium. There were 
difference in percentages by MHC haplotype. The cells from B'" chickens 
had the lowest number of CD4-positive cells at each level of GAT and the 
B'"" haplotype had the highest number of CD8-positive cells. The cells 
from B^' chickens had higher levels of CD4- and CD8-positive cells 
compared to cells from B^ chickens at each level of GAT. The percentages 
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were different as a result of the culture conditions. Freshly collected 
lymphocytes from SI line chickens have been assayed for level of CD4 and 
CDS expression. Cells from b'" chickens were the highest for CD4 
expression and cells from B^"" chickens were the lowest for CDS expression 
with no significant differences between the other SI sublines for either 
marker (Munns 1990). 
When results are examined within blood type, there are some 
interesting differences in the cultured cells. Within the B^' blood type 
there were differences in percentages of CDS-positive cells (suppressor 
type) between Ir-GAT" and Ir-GAT"" chickens. The Ir-GAT^ had higher 
percentages of CDS-positive cells. There was no difference in CDS levels 
between high and low GAT responders within the B^ blood type. Within the 
B' blood type there were differences in percent CD4-positive cells between 
Ir-GAT" and Ir-GAT'" chickens. The Ir-GAT^ cultures had higher levels of 
CD4 positive (helper type) cells at every level of GAT, but the difference 
in the means was only significant when the cells were cultured at the 10 
/ig GAT concentration. 
It is possible that between the two blood types there are different 
mechanisms responsible for the differential response to GAT. The sublines 
within the SI line arose from the same genetic group, but the groups with 
different Ir-GAT types were originated differently (some of the B^ 
chickens were drawn from populations that had been selected for antibody 
response to 5. pullorum). In the blood type, low response could be 
due to induction of suppressor T cells (CDS positive). Within the b' 
blood type high response could be due to the lack of suppression being 
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Induced. Figure 1 (page 18) shows the relationships that exist between 
cells of the immune system. Small alterations in numbers of cells 
involved could cause effects that would be magnified by subsequent steps 
in the reaction. 
Hdla et al .  (1991) reported differences in basal percent of CD4 and 
CD8 lymphocytes in congenic lines of chickens that differ in their 
resistance to Rous sarcoma virus-induced tumors and in their humoral 
immune response to various antigens. Hdla et al. proposed that the 
differences in the ratio of CD4 to CDS cells possibly contributed to RSV 
resistance, but offered no evidence or mechanisms. Cytotoxic T cells 
(that kill abnormal cells) also express the CDS marker and the RSV-
resistant line of chickens had higher levels of CDS expression. In any 
event, small difference in immune cell populations can result in large 
observed differences in immunological traits. Gougeon and Theze (1983) 
attributed differences in immune response to GAT in mouse inbred lines to 
regulatory imbalances (or the ratio of T cell-mediated help to 
suppression) rather than discrete cellular defects (such as inability of 
AFC to present antigen or T cells to respond). Under the appropriate 
conditions (by modifying T cell subset populations) non-responder T cells 
could proliferate in response to GAT and non-responder ARC were able to 
present antigen. 
Complementation Matings 
Matings between two unrelated low GAT-responder sublines of chickens 
(GHS-B" and SI-B'"") resulted in progeny that responded to GAT challenge 
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by producing higher levels of antibody than either of the parental lines. 
The results from the F, generation gave the appearance that gene 
complementation was occurring. The progeny produced by backcrossing the 
F, to SI-B"*- and 6HS-B" chickens (and inter se F, matings) resulted in 
chickens of three blood types (B^'/b", B"/b", and B"/b"). Secondary 
humoral GAT response was most significantly associated with the blood type 
of the progeny. The B" homozygous chickens were low responders to GAT 
and the other two blood types were high responders to GAT. F, progeny 
produced by crossing Sl-B^*" with Sl-B^"" resulted in chickens that were low 
responders to GAT. 
Non-MHC-1inked genes were possibly responsible for the difference in 
the GAT response seen in the F, progeny. Dorf et a1. (1974) examined the 
effects of non-MHC genes on GAT response In mice. They presented evidence 
that non-response or response was due to genes within or linked to the MHC 
and quantitative variation in response was due to non-MHC genes. That 
could explain the results seen with these chickens. The B^' chickens are 
non-responders to GAT, but they may carry complementary genes that allow 
the SI-B"*" chickens (that may be low responders and not non-responders) to 
produce higher levels of antibody. The within-Sl line crosses would not 
have Introduced the complementary alleles that would result in high GAT 
response if those alleles were not in the SI line or were present at a low 
frequency. This would not explain why progeny from F, chickens 
backcrossed to the Sl-B^'*" chickens had the same GAT response as chickens 
backcrossed to the GHS-B" chickens, unless the FJ progeny carried enough 
of the complementary alleles to result in high response to GAT. Since 
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high antibody response to antigen is invariably a dominant trait, the 
alleles probably would not have to be present in homozygous form to exert 
their effect. Dunnington et al. (1989) found that the antibody titer to 
sheep red blood cells (RBC) was determined by the MHC. haplotype and the 
background genome. Although the sheep RBC is a more complex antigen than 
GAT, the results would seem to be dependent on the same mechanisms. 
There are many examples of immune response differences that are not 
attributable to the MHC and show the importance of non-MHC genes. 
Palladino et  a l .  (1977) found differences in resistance to Marek's disease 
among two chicken lines that were identical at the MHC (as shown by 
acceptance of transplanted skin grafts and other immunological tests). 
The same two lines also had quantitative differences in measurements of 
humoral and cellular immunity. Resistance to RSV-induced tumors in some 
inbred chicken lines has been shown to be under partial control of non-MHC 
genes that work to complement the MHC genes (Cutting et al. 1981). 
Gilmour et al .  (1983) even identified the non-MHC genes that had allelic 
variants that resulted in different levels of susceptibility to RSV-
induced tumors. The genes Gilmour found coded for alloantigens on T 
lymphocytes {Ly-4  and Th-1) .  
Summary 
The mechanisms that could result in high or low antibody response in 
the SI line have been examined. T lymphocytes from Ir-GAT high or low 
chickens did not demonstrate any significant propensity to react to the 
antigen in vitro. The index scores (percentage of control) for the 
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sublines show a tendency for the cells from the Ir-GAT" chickens to 
proliferate more than the cells from Ir-GAT^ chickens, but the differences 
were not statistically significant. The variation in response among 
chickens was very high regardless of MHC haplotype. 
All of the experiments conducted in  v i t ro  could have benefitted from 
the availability of a reliable source of pure chicken IL-2. The IL-2 
would have enable longer culture times and allowed more time for the 
differences between haplotypes to become evident. However, the IL-2 could 
have created more problems than it solved. If GAT were more strongly 
antigenic the proliferation in vitro may have been more pronounced, but 
the differences seen in vivo would probably also be different. Genetic 
control of differences in antibody response are more clearly seen when 
antigens of limited antigenic diversity are used. If the antigen 
stimulates more sub-populations of T lymphocytes, the resulting antibody 
production is likely to be larger and obscure differences due to immune 
response genes. 
The antigen-presenting cells do not seem to be a cause of the 
humoral immune response differences in the SI chickens. Results indicate 
that the APC from Ir-GAT"" chickens present antigen better than the APC 
from Ir-GAT" chickens to responder cells of either Ir-GAT type. If the 
antigen processing ability of the APC resulted in the antibody response 
differences this would not be the case. It seems unlikely that the 
antibody differences are due to antigen processing limitations. There is 
the possibility that the culture conditions used simply allowed the APC 
from Ir-GAT*" to function better in processing GAT in  v i t ro .  
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Results from flow cytometry of CD4- and CD8-label1ed cells indicate 
that immune response dichotomy is mediated by populations of effector T 
lymphocytes. The small proliferative response differences in vitro could 
obscure how different the CD4 and CDS percentages between the haplotypes 
may be and the how much it determines the level of antibody response. 
Contrasting the two blood groups, there were differences between Ir-GAT" 
and Ir-GAT*" chickens. The chickens that were low responders to GAT had 
higher levels of CD4 positive (helper type) cells than the Ir-GAT*" 
chickens, at all GAT levels with differences statistically significant 
when the cells were cultured at the 10 /xg level of GAT. The chickens 
differed in percentage of CDS positive cells according to Ir-GAT type at 
every level of GAT. The cells from B'"" chickens have a higher percentage 
of cells that carry the phenotypic marker of the suppressor T cell (CDS). 
The results from the complementation matings point out the effects 
of the MHC or MHC-1inked genes, as well as non-MHC-1inked genes in 
controlling humoral immune response. There is evidence that response to 
GAT in chickens is similar to response to GAT in mice in that response or 
non-response is determined by genes within or linked to the MHC, but the 
amount of antibody produced may be determined by genes that are outside of 
the MHC. 
Future Considerations 
Although by serological and DNA study, Ir-GAT is not a classical MHC 
class I or class II gene, none of the results indicate that Ir-GAT is not 
linked to the MHC. There are still too many gaps in the chicken MHC 
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genomic map (where sequences and gene functions are not known) to allow 
for a complete understanding of immune response and how Ir-GAT is 
mediated. Many research groups are filling in the gaps in the chicken 
MHC, but it will take time. 
Future work in understanding chicken immune response will benefit 
from advances in the basic ability to maintain cells in vitro. For 
example, there is progress being made toward developing recombinant 
chicken IL-2 which would enable the investigation of long term cultures of 
antigen-specific T cell clones. 
Currently, the SI sublines are being developed into congenic lines 
that differ for the MHC-bearing microchromosome. The congenic lines will 
provide additional information regarding the effects of complementary 
genes on immune response to GAT. It will be possible to determine MHC 
effects on antibody production in chickens that have non-MHC complementary 
genes in common. 
The ability to identify genetic differences in populations through 
the techniques of DNA fingerprinting with multi-locus probes are currently 
being applied to investigate the differences in GAT response in the SI 
line. This technique allows diagnostic segments of DNA on gels to be 
identified that are most likely linked to genes that contribute to a 
particular trait. The Identified DNA segments can be isolated and further 
characterized by sequencing and comparison to existing gene data bases. 
As the tools improve, so will the understanding of the mechanisms 
involved. The cellular mechanisms involved in immune response still cause 
dispute among immunologists working with the better studied mammalian 
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system. The results presented in this dissertation only begin to address 
the subject of immune response in chickens. No doubt the work of 
understanding immune response will continue long after this dissertation 
has turned to dust. The possibilities have not been exhausted and there 
are still questions that remain to be answered regarding immune response 
in chickens and how it influences the health of the chicken. 
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Abstract 
Chickens from the Iowa State SI White Leghorn line, selected for 
characteristics of Ea-B serotype, humoral immune response to glutamic 
acid-alanine-tyrosine (Ir-GAT), and response to Rous sarcoma virus (RSV)-
induced tumors, were evaluated for genetic resistance to Marek's disease 
(MD). In the first two trials, sublines that were triple homozygous for 
the 3 traits were challenged with MD virus. Birds of the blood type 
were significantly (P<.001) more resistant to MD than chickens of the 
B^'b" blood type. High responders to GAT were significantly (P<.001) more 
resistant to MD virus than low responders. The RSV classification had no 
detectable association with MD resistance. Chickens challenged with MD 
virus in the third trial were an Fg population produced from inter 5e 
matings of SI chickens heterozygous for the three traits under selection. 
Data from this trial confirmed the increased MD resistance of chickens 
possessing the blood type when associated with genes encoding high 
immune response to GAT. 
1987 Poultry Science 66:571-575. 
(Key words: Marek's disease, major histocompatibility complex, immune 
response, genetic resistance, glutamic acid-alanine-tyrosine) 
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Introduction 
The effectiveness of selection for Marek's disease (MD) resistance 
in poultry is well established. Pioneering work of Hutt and Cole (1948) 
first established the feasibility of such selection. Later work by Cole 
(1968) demonstrated significant differences in MD susceptibility after 
only two generations of selection, suggesting simple genetic control. 
Hanson et âli. (1967) first reported an association between a g locus blood 
group allele and MD resistance. Cole's MD-resistant line N was found to 
be uniformly homozygous for the allele (Pazderka et al., 1975; Briles 
et al., 1977). Other researchers have also identified B locus alleles 
associated with MD resistance or susceptibility (Pazderka fit âl.» 1975; 
Longenecker et il., 1976; Bacon and Witter, 1980; Longenecker and Mosmann, 
1981). 
The g complex is the chicken major histocompatibility complex (MHC) 
for which the erythrocyte alloantigen B (Ea-B) serves as a useful genetic 
marker (Schierman and Nordskog, 1961). Pevzner fit âl»» (1981) reported 
that MD resistance was associated with the immune response region 
identified by humoral Immune response to glutamic acid-alanine-tyrosine 
(Ir-GAT) within the MHC of the Iowa State University SI line. Briles et 
al. (1983) and PI achy et al. (1984) mapped a gene controlling MD 
resistance to the region of the MHC. The gif region, by Plachy's 
definition, contains the immune response region (B-Ll; this finding is 
similar to those of Pevzner fii âl- (1981). Briles and coworkers (1983), 
mapping MD resistance by using recombinants between fidE and fidi regions, 
did not comment on linkage of the and regions in their crossover. 
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Only one generation of SI line chickens segregating for both Ea-B 
and Ir-GAT was challenged with MD virus in the study of Pevzner âl. 
(1981). Selection for the ability to regress RSV-induced tumors has also 
been conducted in the SI sublines and was not addressed in Pevzner's work. 
The present study reports further analysis of MD susceptibility in the 
Iowa State SI Leghorn line with special reference to the association with 
Ea-B, immune response to GAT, and RSV-tumor response. 
Materials and Methods 
Genetic Stocks. The SI line originated from a cross of two 
commercial inbred lines (Nordskog st al., 1973). It has been maintained 
since 1978 in sublines selected for homozygous Ea-B serotype or 
b"b^') and for the humoral immune response to the amino acid polymer, GAT 
(Pevzner gt âl.» 1978). More recently, the sublines were further selected 
for resistance or susceptibility to Rous sarcoma virus (RSV)-induced 
tumors from information on sibling tests. This study used 8 sublines, 
representing all triple homozygous combinations of Ea-B (fi' or fi"), Ir-GAT 
(high or low) and RSV response (regressor or progresser). Each generation 
was produced from five males of each subline which were mated by 
artificial insemination to four or five nonsib hens of the same subline. 
The breeders were selected to represent the appropriate Ea-B and RSV type, 
and possess optimum response to GAT (either high or low, as appropriate). 
Ten to 20% of the progeny in each generation ^ ere selected as breeders. 
The inbreeding coefficients of Trial 2 sublines averaged .40 (Cheng @1 
âl., 1985). 
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The first two trials utilized 2 subsequent generations of the 8 
sublines described previously. The third trial of SI chickens utilized an 
Fg population, derived from matings of B^' Ir-GAT high/B^ Ir-GAT low X B^' 
Ir-GAT high/B^ Ir-GAT low and B" Ir-GAT low/B^ Ir-GAT high X B^' Ir-GAT 
low/B^ Ir-GAT high matings (Figure 1). No RSV designation was assigned to 
the chickens of this population, since 3 different genotypes could be 
generated from each mating. Two of the six haplotypes produced were 
phenotypically identical (bV' Ir-GAT high) since high response to GAT is 
a dominant trait. In some birds, however, the Ir-GAT high gene was linked 
with and in others Ir-GAT was linked with The data from the 
phenotypically identical groups were pooled because the incidences of MD 
among them were not significantly different. This yielded 5 genetic 
groups for analysis. 
Marek's Disease Challenge. Challenge tests for MD were carried out 
at the Rutger's Poultry Health Laboratory under the supervision of Dr. I. 
Kujdych. Two-day old chicks were inoculated intraperitoneally with .25 ml 
(2,500 PFU) of the JM isolate of MD virus (provided by R. Witter, RPRL, 
East Lansing, MI). The chicks were housed together in a floor pen and 
received feed and water ad libitum. All birds were necropsied for 
evidence of gross MD lesions at death or at the termination of the studies 
at 17 weeks. 
Chickens in this study were classified as susceptible to Marek's. 
disease if they either died from MD before 17 weeks or survived to the 
termination of the experiment and showed MD lesions upon necropsy. 
Analysis of variance was performed using percentage susceptible to MD 
113 
within each group as the variable and traits of selection as sources of 
variation. Significance of differences between genetic groups were tested 
on the basis of the statistic. 
Results and Discussions 
The results from trials 1 and 2 are reported individually and are 
also shown pooled because the difference between these trials was not 
significant (Tables 1 and 2). The effects of Ea-B, Ir-GAT, and their 
interaction were highly significant sources of variation in trials 1 and 2 
(Table 1). Classification for RSV response had no effect on MD 
susceptibility, and is not included in the data presented in Table 2. The 
Ir-GAT high sublines were the most resistant to MD (Table 2 and 
Figure 2). Association of Ir-GAT with resistance to MD in the SI line was 
earlier reported by Pevzner st al. (1981). The association of MD 
resistance with the B-F/B-L subregion of the MHC is also congruent with 
findings of Briles et al. (1983) and Plachy et al. (1984). 
In this first investigation of association between RSV response and 
MD resistance in the SI line, chickens differing in RSV classification 
(progressor or regressor) did not differ in incidence of MD (Table 1 and 
Figure 2). Direct selection for RSV response seemed not to influence MD 
resistance, even though both are virally-induced tumors. Calnek ëï al. 
(1975) also reported that the incidence of MD and susceptibility to 
progressive RSV-induced tumors were not necessarily correlated. 
In trial 3, a challenge of Fg birds, the Ir-GAT high group was 
significantly different from all the other groups in incidence of MD 
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(Table 2 and Figure 3). Analysis of variance by haplotype showed that the 
genetic group (combination of Ea-B genotype and Ir-GAT phenotype) was a 
significant source of variation in incidence of MD (Table 3). Analysis of 
Ea-B X Ir-GAT interaction could not be carried out in trial 3, as it had 
been in trials 1 and 2, because of the heterozygous individuals tested in 
trial 3. 
Data from all three trials show that Ir-GAT high chickens are 
more resistant to MD than either or Ir-GAT low chickens. These 
results are congruent with those of Pevzner gt al. (1981). The relatively 
greater resistance, compared to other haplotypes, of the Ir-GAT high 
haplotype to MD has persisted for several generations in the SI 
population. Trial 3 of this experiment extends results of Pevzner et al. 
(1981) by testing an Fg population and definitively linking resistance to 
MD with genes controlling immune response to GAT. 
The difference in relative resistance to MD of the Ir-GAT low 
birds between the sublines of trials 1 and 2 and the Fg population of 
trial 3 suggests a role for complementary gene loci outside of the MHC. 
Fredericksen &t al. (1977) reported 2 non-MHC loci that code for 
lymphocyte alloantigens influencing MD resistance. Possibly, the 
generation of an F^ population from the homozygous sublines resulted in a 
reassortment of complementary loci. Future MD challenge of congenic lines 
of chickens with the SI MHC haplotypes-lines that are currently in 
development- should help to clarify the role of MHC versus non-MHC loci in 
MD resistance. 
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Table 1. Analysis of variance of factors affecting the incidence of 
Narek's disease: Trials 1 and 2 
Trial 1 Trial 2 Pooled data, Trials 
1 and 2 
Source df MSxlO"' df MSxlO"' df 1 MSxlO"^ 
Trial • • • • • • • • ... 1 5 
Sex 1 3 1 67 1 49 
Ea-B^ 1 1450" 1 1233" 1 2679** 
Ir-GAT' 1 
O
 
C
O
 C
O
 1 315" 1 645" 
RSV* 1 62 1 5 1 52 
Ea-B*Ir-GAT 1 143 1 115* 1 257* 
Other 1st order 
interactions 
5 51 5 20 5 24 
Error 5 18 5 6 20 20 
^Mean square. 
^Ea-B - Erythrocyte alloantigen B. 
'ir-GAT " Immune response to glutamic acid-alanine-tyrosine. 
*RSV = Rous sarcoma virus. 
^Tested individually, pooled for clarity. 
*P<.01 
"P<.001 
Table 2. Incidence of Harek's disease (MD+) in the SI line\ 
Trial 1 Trial 2 Pooled data. 
Trials 1 & 2 
Trial 3 
B Genotype Ir-GAT? 
Phenotype 
# 
at 
risk 
% HD+ # 
at 
risk 
% MD+ # 
at 
risk 
% MD+ # 
at 
risk 
% MD+ 
High 118 37.3= 139 45.3= 257 41.6" 56 42.1" 
Low 87 87.4" 81 80.2" 168 83.9" 77 43.0" 
High 69 4.3= 125 6.4= 194 5.7= 49 10.2" 
B^B^ Low 143 11.2= 67 16.4= 210 12.9* 39 46.2" 
High • • • ... ... ... ... ... 112* 40.2" 
"'•^Groups within a column with different superscripts are significantly 
different in incidence of HD {P<.05). 
^Rous sarcoma virus classification had no effect and is ignored for 
presentation of genetic group means. 
^Ir-GAT = Immune response to glutamic acid-alanine-tyrosine. 
^Ir-GAT High dominant over Ir-GAT Low. 
^Includes Ir-GAT High/fi^' Ir-GAT Low and B^ Ir-GAT Low/fi^' Ir-GAT High 
genotypes. 
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Table 3. Analysis of variance of factors affecting the incidence of 
Harek's disease: Trial 3 
Source of variation df 1 MS X 10'^ 
Sex 1 .4 
Ea-B^, Ir-GAT' 4 46* 
Error 4 3 
^Mean square. 
^Ea-B = Erythrocyte alloantigen B. 
^Ir-GAT = immune response to glutamic acid-alanine-tyrosine. 
Ea-B and Ir-GAT classifications are combined as one factor for 
analysis (see Materials and Methods section for description of 
the five genetic groups). 
*P<.01. 
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Figure Legends 
Figure 1. Pedigree (without inclusion of RSV classification) of the 
population challenged with Marek's disease (MD) virus. H and 
L represent immune response to glutamic acid-alanine-tyrosine 
(Ir-GAT) (High and Low, respectively). Chickens 
representative of the sublines of the P, generation were 
challenged in the first two trials. The heterozygous chickens 
(F,) were not challenged with MD virus. The numbers of chicks 
of the Fg population challenged in the third trial are given. 
The Fg haplotypes within the box were phenotypically identical 
(flV Ir-GAT High). 
Figure 2. Incidence of Marek's disease (MD) in SI line chickens 
challenged with JM strain of MD virus. Pooled results from 
trials 1 and 2. Eight sublines are represented, based on 
erythrocyte alloantigen B (Ea-B), immune response to glutamic 
acid-alanine-tyrosine (Ir-GAT), and Rous sarcoma virus (RSV) 
response (regressor or progressor). 
Figure 3. Incidence of Marek's disease (MD) in SI line F^ chickens 
(erythrocyte alloantigen B (Ea-B) and immune response to 
glutamic acid-alanine-tyrosine (Ir-GAT)), Trial 3. Five 
groups are represented as described in Materials and Methods. 
The Ir-GAT High represents the pooled response of two 
haplotypes. 
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